# Product Strategy: AI Research Notebook

> **Document**: Product Strategy  
> **Date**: 2025-07-26  
> **Author**: Product Strategy Agent  
> **Based on**: Phase 1 Research (Market Research, Competitor Analysis, Revenue Research, User Pain Points)  

---

## 1. Product Name

### Option A: **CiteMind**
*Rationale*: Emphasizes the citation-native workflow and knowledge mapping. "Cite" signals academic/professional rigor; "Mind" signals the knowledge graph and visual thinking. Short, memorable, .com likely available. Appeals to researchers, lawyers, and consultants who need traceable thinking.

### Option B: **Synthesis**
*Rationale*: Directly names the core value proposition — synthesizing documents, annotations, and AI into coherent knowledge. Elegant, professional, suggests intelligence and higher-order thinking. Works well for enterprise buyers. The .com may be taken but .io or .app work.

### Option C: **Annotelligence**
*Rationale*: A portmanteau of "annotation" and "intelligence." Immediately signals the core differentiation: AI that understands and reasons from your annotations. Unique and ownable. Slightly playful but still professional.

### Option D: **ResearchForge**
*Rationale*: "Forge" implies building, crafting, and shaping knowledge. Suggests a workspace where raw research materials are forged into insights. Strong for academic and professional research teams. Evokes craftsmanship and productivity.

### Option E: **Driftboard**
*Rationale*: "Drift" suggests the fluid, non-linear thinking process that the product enables. "Board" signals the visual workspace. Light, modern, and appeals to creative researchers and visual thinkers. Less academic, more design-forward.

### **Selected Name: CiteMind**

**Why CiteMind wins:**
- It captures the two most important differentiators: **citation-native workflow** and **knowledge mapping**
- It sounds like a serious tool for serious work — not a toy or a social app
- It is short (8 letters, 2 syllables), easy to spell, and works across cultures
- It positions against AI chat tools that "hallucinate" by signaling *traceability* and *source-grounding*
- The .com/.io domain is likely available or obtainable at reasonable cost
- It works for all target personas: PhD students, lawyers, consultants, R&D scientists

---

## 2. Product Vision

### One-Sentence Vision
> **CiteMind is the first research workspace where every AI insight, every visual connection, and every written note is automatically traced back to its source document.**

### One-Paragraph Vision

Modern researchers, knowledge workers, and teams are drowning in documents. They open PDFs in one app, take notes in another, manage references in a third, and run AI queries in a fourth — losing context, traceability, and time at every switch. CiteMind replaces this fragmented toolchain with a single, AI-native workspace where **deep PDF reading, visual knowledge mapping, and source-grounded AI reasoning** happen together. Every annotation, every note, every AI-generated insight is automatically linked to its originating document and position. Users build living knowledge graphs from their reading, collaborate in real time on research synthesis, and export professional deliverables with properly formatted citations — all without leaving the workspace. CiteMind does not bolt AI onto a note-taking app; it architecturally integrates document intelligence, visual thinking, and generative AI from the ground up, making the research process faster, more rigorous, and more discoverable.

---

## 3. Target Users

### Primary Personas

#### Persona 1: **Graduate Researcher ("Sam")**
- **Age**: 24–32
- **Role**: PhD student, postdoc, or research master's student
- **Context**: Reads 50–200 papers per year. Writes literature reviews, thesis chapters, and conference papers. Uses Zotero + Obsidian/Notion + PDF reader + ChatGPT/NotebookLM today.
- **Pain points**: Switching between tools destroys flow. Annotations trapped in PDF readers. AI answers are untraceable. Literature reviews take weeks. Citation formatting is tedious.
- **Willingness to pay**: $10–25/month (often funded by advisor/lab grant)
- **Decision maker**: Often self-directed; institutional adoption driven by faculty
- **Estimated market size**: 3M+ graduate students globally; 1M+ active researchers in R1 universities

#### Persona 2: **Legal Researcher / Litigator ("Alex")**
- **Age**: 28–45
- **Role**: Associate attorney, paralegal, or legal researcher at a law firm or in-house counsel
- **Context**: Reviews case files, deposition transcripts, contracts, and regulatory documents. Needs to synthesize facts across hundreds of pages and build argument maps.
- **Pain points**: Document review is manual and expensive. Case facts scattered across files. No visual way to map arguments. AI tools lack citation to specific page/line.
- **Willingness to pay**: $50–150/user/month (firm budgets)
- **Decision maker**: Partners or IT directors; trialable by individual practitioners
- **Estimated market size**: 1.3M lawyers in the US alone; legal tech spend growing 15% YoY

#### Persona 3: **R&D / Industry Research Scientist ("Priya")**
- **Age**: 30–50
- **Role**: Research scientist, R&D engineer, or technical lead at a technology or pharma company
- **Context**: Reviews patents, technical papers, competitor filings, and internal reports. Needs to synthesize findings for product decisions and IP strategy.
- **Pain points**: Proprietary documents cannot be uploaded to public AI tools. No tool connects internal documents with external literature. Knowledge walks out the door when researchers leave.
- **Willingness to pay**: $50–200/user/month (enterprise R&D budgets)
- **Decision maker**: VP of R&D, Chief Scientific Officer, IT procurement
- **Estimated market size**: 2M+ R&D professionals in Fortune 1000; enterprise research spend is $800B+

#### Persona 4: **Management / Strategy Consultant ("James")**
- **Age**: 26–40
- **Role**: Consultant at MBB, Big 4, or boutique firm
- **Context**: Reads industry reports, client documents, and expert transcripts. Builds synthesis decks for partners. Works in teams with tight deadlines.
- **Pain points**: Client documents are sensitive and cannot leave the firm's environment. Current tools are slow for multi-document synthesis. Deck building from research is manual.
- **Willingness to pay**: $30–100/user/month (firm licenses)
- **Decision maker**: Engagement manager or knowledge management team
- **Estimated market size**: 1M+ management consultants globally; consulting industry revenue $350B+

### Secondary Personas

#### Persona 5: **Undergraduate Researcher ("Mia")**
- **Age**: 19–23
- **Role**: Junior/senior working on capstone, honours thesis, or research assistantship
- **Context**: Learning research methods. Reads fewer papers but needs more guidance. Price-sensitive.
- **Pain points**: Overwhelmed by research tools. Needs simpler onboarding than Zotero + Obsidian combo.
- **Willingness to pay**: $5–15/month (often personal funds; strong student-discount sensitivity)
- **Decision maker**: Self-directed or recommended by faculty

#### Persona 6: **Journalist / Investigative Reporter ("Carlos")**
- **Age**: 28–50
- **Role**: Investigative journalist, fact-checker, or documentary researcher
- **Context**: Reviews FOIA documents, court records, interview transcripts, and leaked materials. Needs to connect facts across sources and maintain source provenance.
- **Pain points**: No tool designed for investigative document synthesis. Fact-checking is manual. Source attribution is critical for legal safety.
- **Willingness to pay**: $15–30/month (often funded by newsroom or grants)

#### Persona 7: **Knowledge Manager / Librarian ("Dr. Chen")**
- **Age**: 35–55
- **Role**: University librarian, research support officer, or corporate knowledge manager
- **Context**: Supports researchers with tools and training. Advocates for institutional licenses.
- **Pain points**: Existing tools are too fragmented for training. No single tool supports the full research lifecycle. Institutional analytics on research activity are missing.
- **Willingness to pay**: $20–50/user/month (institutional volume pricing)
- **Decision maker**: Influences university-wide or enterprise procurement

---

## 4. Primary Use Cases

### Use Case 1: Literature Review & Synthesis (Academic)
**Actor**: Graduate researcher (Sam)  
**Scenario**: Sam is writing a systematic literature review on "transformer architectures for protein structure prediction." She has 87 papers in her Zotero library, plus 23 newly downloaded PDFs from arXiv and PubMed.

**Workflow in CiteMind**:
1. Sam imports her papers (bulk PDF upload + Zotero sync). CiteMind extracts metadata, OCRs scanned pages, and indexes all text.
2. She reads the first paper in the built-in PDF viewer, highlights key claims, and creates "extracted snippets" that link back to exact page locations.
3. She asks the AI: "What are the main architectural differences between AlphaFold2 and ESM-3?" The AI answers by comparing specific passages across 6 papers, with inline citations to the exact highlighted snippets.
4. She drags key snippets onto the Research Board, arranging them by theme ("attention mechanisms," "contact prediction," "multimeric assemblies"). The AI suggests connections between related snippets.
5. The knowledge graph automatically shows papers clustered by shared concepts. Sam discovers a paper she had not yet read that bridges two of her themes.
6. She exports her synthesis to a Word document with proper APA citations — every claim is footnoted to the exact source passage.

**Value**: Reduces literature review time from 3–4 weeks to 5–7 days. Eliminates copy-paste errors. Makes missed connections discoverable.

---

### Use Case 2: Case Argument Mapping (Legal)
**Actor**: Litigator (Alex)  
**Scenario**: Alex is preparing for a product liability trial. The case file contains 2,400 pages of deposition transcripts, 18 expert reports, and 340 internal emails.

**Workflow in CiteMind**:
1. Alex's firm uploads the case documents to a secure, SOC-2-compliant workspace. CiteMind indexes all documents and creates a searchable corpus.
2. Alex highlights key admissions in deposition transcripts and links them to contradictory statements in expert reports.
3. On the Research Board, Alex builds a visual argument map: plaintiff's claims on the left, defense counterarguments on the right, with evidentiary snippets pinned to each node.
4. Alex asks the AI: "Find all instances where Dr. Smith's testimony contradicts the 2019 FDA guidance document." The AI returns 4 matches with inline citations.
5. The knowledge graph surfaces an unexpected connection: an internal email from 2018 references the same manufacturing defect mentioned in a 2021 consumer complaint.
6. Alex exports the argument map and supporting evidence to a PDF brief with hyperlinked citations to the exact document and page.

**Value**: Reduces document review time by 40–60%. Surfaces connections human reviewers miss. Creates defensible, traceable arguments.

---

### Use Case 3: Competitive & Technical Intelligence (R&D)
**Actor**: Research scientist (Priya)  
**Scenario**: Priya's biotech startup is evaluating a new CRISPR delivery platform. She needs to synthesize 50+ patent filings, 12 peer-reviewed papers, and 8 competitor press releases.

**Workflow in CiteMind**:
1. Priya uploads all documents to a private project workspace. CiteMind extracts claims, figures, and technical parameters from patents.
2. She highlights key delivery mechanisms and efficacy data across papers. The AI auto-suggests a comparison table of "delivery vector vs. tissue specificity vs. editing efficiency."
3. On the Research Board, Priya maps the patent landscape: her company's patents in blue, competitor patents in red, white-space opportunities in green.
4. She asks the AI: "What prior art challenges might our new lipid nanoparticle formulation face?" The AI analyzes 12 patents and flags 3 overlapping claims with cited passages.
5. The knowledge graph reveals that two seemingly unrelated papers share a co-author who has since founded a competing startup.
6. Priya exports the intelligence brief to a PowerPoint deck with citations, ready for the board meeting.

**Value**: Accelerates due diligence from weeks to days. Surfaces IP risks and competitive blind spots early. Creates board-ready deliverables.

---

### Use Case 4: Client Research & Synthesis (Consulting)
**Actor**: Strategy consultant (James)  
**Scenario**: James is preparing a market entry strategy for a healthcare client. He has 30 expert interview transcripts, 15 industry reports, and the client's internal financial data.

**Workflow in CiteMind**:
1. James's team creates a shared project workspace. All consultants upload their interview notes and documents.
2. Each consultant highlights key insights in their assigned documents. The AI aggregates all highlights by theme ("pricing pressure," "regulatory barriers," "channel dynamics").
3. On the shared Research Board, the team builds a "market map" with competitor positions, customer segments, and regulatory milestones.
4. The AI synthesizes: "What are the 3 biggest risks to entering this market, based on the expert interviews?" Each risk is backed by direct quotes from named experts.
5. The knowledge graph shows that two experts cited the same failed competitor launch — a pattern the team might have missed.
6. James exports the synthesis to a consulting-style presentation with source citations and a data room appendix.

**Value**: Reduces synthesis time from 2–3 days to <1 day. Ensures no insight is lost. Creates defensible, client-ready deliverables.

---

### Use Case 5: Thesis & Dissertation Writing
**Actor**: Graduate researcher (Sam)  
**Scenario**: Sam is in the writing phase of her PhD thesis. She has 200+ annotated papers, a messy Obsidian vault, and 5 chapters to write.

**Workflow in CiteMind**:
1. Sam imports her existing notes and PDFs. CiteMind maps her reading history into a structured knowledge graph.
2. She opens the chapter outline view and assigns relevant papers to each section.
3. While writing, she highlights a claim and the AI suggests: "You have 3 papers that support this claim. Would you like to insert a citation?" She clicks yes; the citation is formatted in her chosen style (Chicago).
4. The AI flags: "This claim contradicts the finding in Smith et al. 2023. Would you like to add a counterargument?" Sam drags the counterargument into her text.
5. The knowledge graph shows that her Chapter 3 and Chapter 5 are both citing the same paper for different claims — a potential structural issue she addresses.
6. She exports the full thesis with proper formatting, a bibliography auto-generated from all cited sources, and a hyperlinked appendix of all annotations.

**Value**: Keeps writing and research connected. Prevents citation errors. Surfaces structural problems in the argument.

---

### Use Case 6: Teaching & Course Preparation
**Actor**: Professor / Knowledge Manager (Dr. Chen)  
**Scenario**: Dr. Chen is teaching a graduate seminar on "AI Ethics in Healthcare." She needs to curate readings, create discussion guides, and track student engagement.

**Workflow in CiteMind**:
1. Dr. Chen creates a shared project for the course and uploads all assigned readings.
2. She pre-annotates key passages with discussion prompts that appear as "guide cards" when students read.
3. Students highlight passages and add their own notes. The AI suggests connections between student annotations and course themes.
4. On the class Research Board, students collaboratively map the debate: "autonomy vs. beneficence," "algorithmic bias," "consent in AI diagnostics."
5. Dr. Chen reviews the knowledge graph to see which papers are most frequently cited by students and which themes are underexplored.
6. She exports the class synthesis to a course report and a reading list for next semester.

**Value**: Transforms reading from passive consumption to active synthesis. Gives instructors visibility into student thinking. Builds reusable course materials.

---

### Use Case 7: Multi-Document Contract Review (Enterprise)
**Actor**: In-house counsel (Alex)  
**Scenario**: Alex's company is acquiring a startup. She must review 12 master service agreements, 45 SOWs, and 8 employment contracts for IP assignment clauses.

**Workflow in CiteMind**:
1. Alex uploads all contracts to an enterprise-grade secure workspace with audit logging.
2. She asks the AI: "Extract all IP assignment clauses and compare them across the employment contracts." The AI returns a structured table with citations to each contract and clause number.
3. She highlights risky clauses (e.g., overly broad assignments) and pins them to the Research Board organized by risk level.
4. The AI flags: "Contract 7 contains a non-compete clause that may be unenforceable in California. Here is the relevant statutory language and 3 similar cases."
5. The knowledge graph shows that 4 of the SOWs reference the same expired master agreement — a liability the team had not caught.
6. Alex exports the risk register to Excel and the legal memo to Word with full citations.

**Value**: Reduces contract review time by 50–70%. Catches cross-document inconsistencies. Creates audit-ready documentation.

---

## 5. Core Workflow

The CiteMind workflow is designed around the **natural research lifecycle**: **Read → Extract → Connect → Synthesize → Export**. Each step is AI-assisted, visually supported, and citation-native.

### Step 1: Import & Ingest
- **Bulk upload** PDFs, Word docs, PowerPoints, images, and text files
- **Sync with Zotero/Mendeley** to import existing libraries with metadata
- **Auto-extraction**: OCR for scanned documents, table extraction for data, figure detection for images
- **Auto-metadata**: CiteMind extracts title, authors, journal, DOI, and abstract using AI and CrossRef lookup
- **Duplicate detection**: Warns if the same paper is uploaded twice

### Step 2: Read & Annotate
- **PDF viewer**: Fast, smooth rendering even for 500+ page documents. Supports text selection, highlight (yellow, green, blue, pink), underline, strikethrough, and freehand ink (on tablet/stylus)
- **Annotation layers**: Each user has their own annotation layer; shared projects show all layers with toggle filters
- **Extracted snippets**: Any highlight can be "promoted" to a snippet — a card that links back to the exact page, paragraph, and character position in the source PDF
- **Note-on-annotation**: Users can add typed or voice notes to any highlight
- **AI pre-read**: Before opening a paper, the AI offers a structured summary (Abstract, Methods, Key Findings, Limitations) with links to jump to relevant sections

### Step 3: Ask & Reason
- **Document chat**: Ask natural-language questions about any open document. Answers are grounded in the document text with inline citations to highlighted passages
- **Multi-document chat**: Ask questions across all documents in a project. The AI retrieves relevant passages, synthesizes an answer, and cites each claim to its source document and page
- **Annotation-aware AI**: The AI understands which passages the user has highlighted and weights them in answers. It can answer: "What did I highlight about X?" or "Find passages that contradict my highlighted claim about Y"
- **Synthesis prompts**: Pre-built prompts for common tasks: "Summarize the methodology," "Compare findings across papers," "Identify gaps in the literature," "Extract all datasets used"

### Step 4: Map & Connect (Research Board)
- **Visual workspace**: An infinite canvas where users drag snippet cards, note cards, image cards, and AI-generated insight cards
- **Connection drawing**: Draw lines between cards. Label connections ("supports," "contradicts," "extends," "methodological basis of")
- **Auto-suggest connections**: The AI analyzes card content and suggests: "This finding from Paper A seems to contradict this claim from Paper B. Would you like to connect them?"
- **Clustering**: The AI can auto-group cards by theme, method, or timeline
- **Nested boards**: Create sub-boards within boards for hierarchical organization (e.g., a board per chapter)
- **Template boards**: Start from templates: "Literature Review," "Argument Map," "Competitive Landscape," "Thesis Outline"

### Step 5: Discover & Navigate (Knowledge Graph)
- **Auto-generated graph**: As snippets and notes are created, the knowledge graph auto-builds, showing documents, concepts, authors, and claims as interconnected nodes
- **Graph views**: Switch between "Document view" (papers connected by shared citations), "Concept view" (ideas connected by co-occurrence), and "Author view" (researchers connected by collaboration and citation)
- **Graph filtering**: Filter by date, project, tag, or AI-detected theme
- **Discovery**: Click a concept node to see all papers, snippets, and notes that mention it. The AI suggests: "3 papers you have not read discuss this concept"
- **Pathfinding**: Find the shortest path between two concepts (e.g., "How does 'transformer architecture' connect to 'protein folding'?")

### Step 6: Collaborate & Review
- **Shared projects**: Invite team members with role-based permissions (viewer, commenter, editor, admin)
- **Real-time cursors**: See where collaborators are working on the Research Board (MVP: async with presence indicators; post-MVP: real-time sync)
- **Comment threads**: Discuss specific snippets or board regions. Comments are threaded and resolved.
- **Activity feed**: See who added what, when. Filter by user, document, or action type.
- **Review mode**: Share a read-only or comment-only version with advisors, clients, or reviewers.

### Step 7: Export & Deliver
- **Export formats**: Markdown, Word (.docx), PDF, PowerPoint (.pptx), HTML, LaTeX, and BibTeX/RIS
- **Citation-native export**: Every exported document includes properly formatted citations and, where supported, hyperlinks back to the source passages in CiteMind
- **Export scopes**: Export the entire project, a single Research Board, a filtered subset, or a linear document derived from a board layout
- **Presentation mode**: Turn any Research Board into a slide-deck-style presentation with navigation arrows and speaker notes
- **Integration**: One-click export to Overleaf, Google Docs, Notion, or Obsidian

---

## 6. Differentiation Analysis

### 6.1 Differentiation from LiquidText

| Dimension | LiquidText | CiteMind |
|-----------|------------|----------|
| **AI document understanding** | None | Native, annotation-aware, multi-document reasoning |
| **Knowledge graph** | None (visual workspace only) | Auto-built, semantic, navigable |
| **Citation management** | None | Native citation export, Zotero integration, formatted bibliographies |
| **Collaboration** | Limited (Cloud version only) | Project-based with permissions, comments, activity feeds |
| **Export to deliverables** | PDF/image only | Word, PowerPoint, LaTeX, Markdown with live citations |
| **Multi-document AI chat** | None | Core feature — ask across entire project |
| **Platform** | iPad/Mac/Web | Web-first, cross-platform, local-first option |
| **Pricing** | One-time or cloud sub | Freemium SaaS with clear upgrade path |

**LiquidText's strength**: The best-in-class visual PDF workspace. The "pull excerpts into a workspace" interaction is intuitive and unmatched.

**CiteMind's response**: Match the visual workspace quality, then add AI that understands the excerpts, a knowledge graph that connects them, and export that makes them useful beyond the app. LiquidText is a reading tool; CiteMind is a research intelligence platform.

---

### 6.2 Differentiation from NotebookLM

| Dimension | NotebookLM | CiteMind |
|-----------|------------|----------|
| **PDF annotation** | None (upload-only) | Deep annotation with highlight, ink, notes, snippets |
| **Visual workspace** | None | Infinite canvas Research Board with connections |
| **Knowledge graph** | None | Auto-built semantic graph |
| **Citation precision** | Source links (page-level) | Character-level citations with snippet cards |
| **Annotation-aware AI** | No (AI does not see annotations) | AI reasons from user's highlighted passages |
| **Export** | Audio, text, limited formats | Professional formats with citations |
| **Collaboration** | Limited sharing | Team workspaces with permissions |
| **Reference manager** | None | Zotero/Mendeley sync |
| **Offline** | None (cloud-only) | Local-first with sync |
| **Privacy model** | Google's data practices | Clear data policy, enterprise self-hosting option |

**NotebookLM's strength**: Viral AI audio overviews and Google's model access. The "chat with your documents" UX is simple and powerful.

**CiteMind's response**: NotebookLM is a chatbot with document context. CiteMind is a workspace where AI is one layer of a structured research process. Users who need to *do* research (not just chat about it) will find NotebookLM's lack of annotation, visual mapping, and export crippling.

---

### 6.3 Differentiation from Obsidian

| Dimension | Obsidian | CiteMind |
|-----------|----------|----------|
| **PDF workspace** | Plugin-based, limited | First-class, native PDF viewer with annotation |
| **AI features** | Plugin-based (varies) | Native, architecturally integrated |
| **Citation management** | Plugin-based (Citations, Zotero Integration) | Native, with Zotero sync and auto-formatting |
| **Visual workspace** | Canvas (good but basic) | Research Board with AI-suggested connections |
| **Knowledge graph** | Backlink graph (local, static) | Dynamic, AI-enhanced semantic graph |
| **Multi-document AI chat** | None | Core feature |
| **Collaboration** | Publish/Sync (paid) | Built-in project sharing |
| **Export** | Markdown + plugins | Professional formats with live citations |
| **Onboarding** | Steep learning curve | Guided, template-driven, 5-minute to first value |
| **Data model** | Local Markdown files | Local-first with cloud sync; documents + annotations + graph |

**Obsidian's strength**: The most powerful local-first knowledge graph, infinite customization via plugins, and a passionate community. It is the default for serious PKM users.

**CiteMind's response**: Obsidian is a *general* knowledge tool. CiteMind is purpose-built for *document-based research*. The PDF annotation, AI reasoning, and citation-native workflow are impossible to replicate in Obsidian without a fragile plugin stack. For researchers who live in PDFs, CiteMind will feel native where Obsidian feels like a workaround.

---

### 6.4 Differentiation from Notion

| Dimension | Notion | CiteMind |
|-----------|--------|----------|
| **PDF handling** | Embed only (no annotation, no AI) | Deep reading, annotation, AI reasoning |
| **AI features** | AI assistant (general purpose) | Research-specific, document-grounded, annotation-aware |
| **Citation management** | Manual or database hacks | Native, automated, formatted export |
| **Visual workspace** | None (databases + pages) | Infinite canvas with snippet cards |
| **Knowledge graph** | None (databases are relational, not semantic) | Auto-built semantic graph from documents |
| **Multi-document AI** | None | Core feature — reason across entire project |
| **Research workflow** | Not designed for research | Purpose-built for the research lifecycle |
| **Export** | Good general export | Research-specific export with citations |
| **Performance** | Can be slow with large pages | Optimized for large documents and many files |
| **Offline** | Limited | Local-first with sync |

**Notion's strength**: The best all-in-one workspace for teams. Databases, wikis, and project management are unmatched. 100M+ users create strong lock-in.

**CiteMind's response**: Notion is a *general workspace*. CiteMind is a *research workspace*. Researchers who try to use Notion for deep PDF reading, literature synthesis, and citation management end up with brittle database hacks and manual copy-paste workflows. CiteMind integrates with Notion (export to Notion pages) so users can keep Notion for project management and use CiteMind for research.

---

### 6.5 Differentiation from Zotero

| Dimension | Zotero | CiteMind |
|-----------|--------|----------|
| **PDF reading** | Basic built-in reader | Best-in-class with deep annotation |
| **AI features** | None | Native, multi-document reasoning |
| **Visual workspace** | None | Research Board with knowledge mapping |
| **Knowledge graph** | None | Auto-built from documents and annotations |
| **Annotation export** | Locked in Zotero database | Portable, linked to snippets, exportable |
| **Collaboration** | Group libraries (basic) | Real-time project workspaces |
| **Export** | Citation formats only | Full document synthesis with citations |
| **AI chat** | None | Core feature |
| **User experience** | Functional, dated | Modern, fast, visually polished |
| **Pricing** | Free (nonprofit) | Freemium with clear value at each tier |

**Zotero's strength**: The academic standard for reference management. Free, open, and institutionally trusted. Deep integration with Word and LaTeX.

**CiteMind's response**: Zotero is a *reference manager*. CiteMind is a *research platform* that includes reference management. CiteMind syncs with Zotero so users do not lose their libraries. The value proposition is: "Keep Zotero for your bibliography, but do your actual research in CiteMind." Over time, as CiteMind's reference management matures, power users may migrate fully.

---

### 6.6 Differentiation from Readwise / Readwise Reader

| Dimension | Readwise Reader | CiteMind |
|-----------|-----------------|----------|
| **PDF annotation** | Highlighting only | Deep annotation + ink + notes + snippet extraction |
| **AI features** | Basic AI summaries | Deep, annotation-aware, multi-document reasoning |
| **Visual workspace** | None | Research Board with connections |
| **Knowledge graph** | None | Auto-built semantic graph |
| **Citation management** | None | Native, with reference manager sync |
| **Multi-document AI** | None | Core feature |
| **Research workflow** | Passive reading + review | Active synthesis + creation |
| **Export** | Text exports | Professional deliverables with citations |
| **Collaboration** | None | Team workspaces |
| **Use case** | Read-it-later, highlight resurfacing | Research intelligence, knowledge creation |

**Readwise's strength**: The best read-it-later and highlight-resurfacing system. Excellent for passive consumption and spaced-repetition learning.

**CiteMind's response**: Readwise is for *reading*. CiteMind is for *researching*. Users who highlight in Readwise are collecting raw material. CiteMind is where that raw material is forged into knowledge. CiteMind could integrate with Readwise (import highlights) to capture users at the consumption stage and graduate them to synthesis.

---

## 7. Why Users Would Switch

### From LiquidText
- "I love LiquidText's visual workspace, but I need AI that understands my excerpts. I paste everything into ChatGPT anyway — CiteMind does that inside the workspace."
- "I spend hours manually copying annotations into Word. CiteMind exports my board directly to a cited document."
- "My research team uses LiquidText individually, but we have no way to collaborate. CiteMind has shared projects."

### From NotebookLM
- "NotebookLM is great for quick summaries, but I can't annotate PDFs or build a visual map of my research. CiteMind does both."
- "I can't trust NotebookLM's citations for my thesis because I can't verify the exact passage. CiteMind shows me the source."
- "I need to export to Word with proper citations for my advisor. NotebookLM can't do that."
- "I don't want my research data in Google's ecosystem. CiteMind has clearer privacy terms."

### From Obsidian
- "I spent 40 hours setting up Obsidian plugins for research, and it still can't handle PDFs well. CiteMind works out of the box."
- "My advisor can't read my Obsidian graph. CiteMind exports to Word with citations they can review."
- "I need AI that reasons across my PDFs, not just my typed notes. Obsidian can't do that."

### From Notion
- "My Notion 'literature database' is a hack. I still read PDFs in Preview and take notes in a separate tool. CiteMind integrates reading, note-taking, and synthesis."
- "Notion's AI doesn't understand my documents. It just writes generic text. CiteMind's AI cites my actual papers."
- "I can't build a visual argument map in Notion. CiteMind's Research Board is built for that."

### From Zotero
- "Zotero manages my references but doesn't help me read or think. CiteMind is where I actually do my research."
- "Zotero's PDF reader is clunky. CiteMind's is fast and annotation-rich."
- "I need AI to help me synthesize across 50 papers. Zotero doesn't have that."

### From Readwise Reader
- "Readwise is where I collect highlights. CiteMind is where I turn them into knowledge."
- "I want to connect my highlights into a visual map. Readwise can't do that."
- "I need to write a literature review from my reading. CiteMind exports the synthesis."

### From Heptabase / Scrintal
- "Heptabase is beautiful for visual notes, but it has no AI and no PDF annotation. CiteMind has both."
- "I can't cite sources from Heptabase into my thesis. CiteMind's export includes citations."
- "Heptabase's AI is basic. CiteMind's AI understands my documents."

### From SciSpace / Elicit / Humata
- "These tools are great for quick Q&A, but I can't annotate or build a knowledge map. CiteMind is a workspace, not just a chatbot."
- "I can't export my SciSpace conversations into a deliverable. CiteMind exports to Word and PowerPoint."
- "I need my AI to know which passages I highlighted as important. These tools treat all text equally."

---

## 8. Why Users Would Pay

### Pricing Evidence from the Market

| Competitor | Pricing | Revenue | User Base | What Users Pay For |
|------------|---------|---------|-----------|------------------|
| **Notion** | $8–15/user/mo | $400–600M ARR | 100M+ users | Collaboration, databases, structure |
| **Readwise** | $6–13/mo | ~$14M ARR | N/A | Highlight aggregation, resurfacing, AI reader |
| **LiquidText** | $8/mo (cloud) or $30 one-time | $1.3M ARR | N/A | Visual PDF workspace, active reading |
| **Heptabase** | $9–54/mo | $1.2–1.7M ARR | N/A | Visual notes, AI features, whiteboarding |
| **SciSpace** | $12–20/mo | N/A | Researchers | Chat with PDF, literature discovery |
| **Elicit** | $10–50/mo | N/A | Researchers | Systematic review automation |
| **NotebookLM Plus** | $20/mo | Google-internal | Viral growth | AI document chat, audio overviews |
| **Obsidian** | $4–8/mo (sync) | $5–15M est. | 1M+ users | Sync, publish, local-first control |
| **Mem** | $12–25/mo | $5–15M est. | N/A | AI memory, automatic organization |

### Willingness-to-Pay Signals from User Pain Points
- Users repeatedly pay for tools that **save time on synthesis** (SciSpace, Elicit, NotebookLM Plus all charge $10–25/mo for AI chat)
- Users pay for **visual thinking** (Heptabase at $9–54/mo, LiquidText at $8/mo)
- Users pay for **citation management** (Zotero storage at $20–120/yr; EndNote at $250+ one-time)
- Users pay for **collaboration** (Notion Business at $15/user/mo; Miro at $16/user/mo)
- The **combination** of these capabilities justifies a premium price because no single tool currently offers the bundle

### CiteMind Pricing Rationale

| Tier | Price | Target Users | Value Proposition |
|------|-------|--------------|-------------------|
| **Free** | $0 | Students, hobbyists | 3 projects, 50 PDFs/project, basic AI, basic export |
| **Pro** | $15/month or $120/year | Graduate researchers, individual consultants | Unlimited projects, 500 PDFs/project, full AI, all export formats, knowledge graph |
| **Team** | $25/user/month or $20/user/year | Research labs, consulting teams, small firms | Shared projects, real-time collaboration, admin controls, priority support |
| **Enterprise** | Custom | Universities, law firms, pharma, tech companies | SSO, audit logging, self-hosting option, custom AI models, dedicated success manager, SLAs |

### Why Users Will Pay CiteMind's Price

1. **Time savings**: A graduate researcher who spends 3 weeks on a literature review could save 1–2 weeks. At 20 hours/week of research time, that's 20–40 hours saved. At $15/hr opportunity cost, that's $300–600 of value for a $15/month subscription.

2. **Tool consolidation**: Users currently pay for 3–5 tools (PDF reader, reference manager, AI chat, note app, whiteboard). At $8 + $0 + $20 + $8 + $0 = ~$36/month, a $15/month tool that replaces most of them is a net savings.

3. **Quality of output**: Professional deliverables with proper citations reduce rejection risk for papers, improve client satisfaction for consultants, and reduce legal exposure for attorneys. This is worth far more than the subscription price.

4. **Enterprise value**: For a law firm, reducing document review time by 50% on a $500/hr associate's time pays for a $100/month license in the first hour saved.

5. **Network effects**: Research teams that adopt CiteMind will pressure collaborators to adopt it for shared project access, creating organic growth.

---

## 9. MVP Scope Definition

### What Should Be Built First (Core MVP)

The MVP must be **useful, impressive, and buildable** in 3–4 months with a small team. The goal is a single, coherent experience that demonstrates the core value proposition: **AI that understands your annotated documents and helps you synthesize them visually.**

#### Tier 1: Essential (MVP Launch)

| # | Feature | Why Essential |
|---|---------|---------------|
| 1 | **User authentication** | Sign-up, login, password reset, OAuth (Google) |
| 2 | **Project workspace** | Create, rename, delete projects. Projects are the top-level container. |
| 3 | **PDF upload** | Drag-and-drop PDF upload, progress indicator, file size validation (up to 50MB) |
| 4 | **PDF viewer** | Fast, smooth-scrolling viewer. Text selection. Page navigation. Thumbnail sidebar. |
| 5 | **Highlighting** | Text highlight in 4 colors (yellow, green, blue, pink). Highlight persists in session. |
| 6 | **Notes on highlights** | Add a typed note to any highlight. Note appears in a sidebar panel. |
| 7 | **Extracted snippets** | "Promote" a highlight to a snippet card. Card links back to exact page/position. |
| 8 | **AI summary** | One-click summary of any uploaded document. Structured: Abstract, Key Findings, Methods, Limitations. |
| 9 | **Ask questions to document** | Natural-language chat with a single document. Answers cite page numbers. |
| 10 | **Basic multi-document search** | Search across all documents in a project by keyword. Results show document + page + excerpt. |
| 11 | **Source-linked answers** | Every AI answer includes a "source" button that jumps to the relevant passage in the PDF. |
| 12 | **Research Board** | Infinite canvas. Drag snippet cards, note cards, and AI insight cards. Basic connection lines. |
| 13 | **Basic knowledge graph** | Auto-generated graph showing documents connected by shared concepts. Static view. |
| 14 | **Export to Markdown** | Export a Research Board or single document's notes to Markdown with citation links. |
| 15 | **Export to PDF** | Export a Research Board to a clean, printable PDF. |
| 16 | **Clean modern UI** | Professional, minimal design. Tailwind CSS or equivalent. Responsive layout. |
| 17 | **Local dev setup** | Easy local development: Docker compose, clear README, environment variables. |

#### Tier 2: High-Value (MVP + 1–2 months)

| # | Feature | Why High-Value |
|---|---------|----------------|
| 18 | **Zotero sync** | Import existing Zotero libraries. Two-way sync for metadata. |
| 19 | **Multi-document AI chat** | Ask questions across all documents in a project. Cite specific documents. |
| 20 | **OCR for scanned PDFs** | Extract text from image-based PDFs and scans. |
| 21 | **Citation formatting** | Export with APA, MLA, Chicago, IEEE, BibTeX formats. |
| 22 | **Board templates** | Pre-built templates: Literature Review, Argument Map, Thesis Outline. |
| 23 | **Tagging & filtering** | Tag documents, snippets, and notes. Filter by tag in search and graph. |
| 24 | **Import from URL** | Paste a DOI, arXiv URL, or PDF URL to auto-fetch and import. |
| 25 | **Dark mode** | Essential for researchers who work at night. |
| 26 | **Keyboard shortcuts** | Power-user shortcuts for highlighting, snippet creation, navigation. |
| 27 | **Document metadata editing** | Correct auto-extracted metadata. Add tags, notes, and custom fields. |
| 28 | **Basic collaboration** | Share a project via link. View-only or comment-only access. |

#### Tier 3: Differentiating (Post-MVP, Months 3–6)

| # | Feature | Why Differentiating |
|---|---------|-------------------|
| 29 | **Real-time collaborative editing** | Multiple users on the same Research Board simultaneously. |
| 30 | **Annotation-aware AI** | AI knows which passages you highlighted and can answer: "What did I highlight about X?" |
| 31 | **AI-suggested connections** | AI analyzes board content and suggests links between related cards. |
| 32 | **Semantic knowledge graph** | Filterable, explorable graph with concept nodes, not just document nodes. |
| 33 | **Export to Word** | Export to .docx with formatted citations and bibliography. |
| 34 | **Export to PowerPoint** | Export a Research Board to a .pptx slide deck. |
| 35 | **Handwriting / ink annotation** | Freehand ink on PDFs (tablet/stylus). Recognize and search ink. |
| 36 | **Version history** | Track changes to a project over time. Revert to previous versions. |
| 37 | **AI writing assistant** | Draft paragraphs from board content with inline citations. |
| 38 | **Bulk operations** | Bulk tag, bulk highlight, bulk export across multiple documents. |
| 39 | **Mobile web** | Responsive mobile web for reading and reviewing on tablet/phone. |
| 40 | **Offline mode** | Local-first storage with background sync. |

### What Should NOT Be Built First (Explicitly Excluded from MVP)

| Feature | Why Excluded | When to Build |
|---------|------------|---------------|
| **Full enterprise admin** | SSO, audit logging, SCIM provisioning are complex and not needed for early adopters | After 500+ Team customers |
| **Complex real-time collaboration** | Operational transformation for concurrent board editing is hard; async collaboration is sufficient initially | Post-MVP, Month 3–6 |
| **Native mobile apps** | Mobile web is sufficient for MVP. iOS/Android native apps are expensive to build and maintain | After product-market fit, Year 2 |
| **Advanced handwriting recognition** | Basic ink is fine; turning handwriting into searchable text requires ML investment | Post-MVP, Month 6+ |
| **Full offline sync** | Local-first with manual sync is acceptable; automatic background sync is complex | Post-MVP, Month 6+ |
| **Complex compliance automation** | SOC 2, HIPAA, GDPR automation is enterprise-only; start with clear policies | When first enterprise deal is $50K+ |
| **Overbuilt analytics** | Dashboards for "research productivity" are nice but not core value | After 10K+ users |
| **Plugin / API ecosystem** | APIs are powerful but require stability guarantees that slow early development | After core product is stable, Year 2 |
| **Advanced NLP pipelines** | Custom entity extraction, relation extraction, and topic modeling are research projects | When AI team is 3+ people |
| **Third-party integrations beyond Zotero** | Mendeley, EndNote, RefWorks integration can wait | After Zotero integration is proven |
| **Voice/audio features** | Audio overviews (like NotebookLM) are viral but not core to the research workflow | Post-MVP if competitive pressure |
| **Public sharing / publishing** | Publishing research boards to the web is a growth feature, not a core workflow | After 5K+ active users |
| **Advanced AI models (custom fine-tuning)** | Using GPT-4/Claude via API is sufficient; custom models require ML infrastructure | After $1M ARR |
| **Video document support** | Transcribing and analyzing video lectures is valuable but a separate feature | Post-MVP, Year 2 |
| **3D / VR knowledge graph** | Immersive graph visualization is futuristic but not demanded by current users | Research experiment only |

---

## 10. Prioritised Backlog

### Legend
- **User Value**: 1–10 (10 = transformational for target users)
- **Build Difficulty**: 1–10 (10 = requires novel research or massive infrastructure)
- **Differentiation**: 1–10 (10 = no competitor has this, or we do it dramatically better)
- **MVP Required**: Yes / No / Post-MVP
- **Version**: Target release milestone

| Feature | User Value | Build Difficulty | Differentiation | MVP Required? | Version |
|---|---:|---:|---:|:---|:---|
| **User auth (email, Google OAuth)** | 10 | 3 | 2 | Yes | MVP |
| **Project workspace (CRUD)** | 10 | 3 | 2 | Yes | MVP |
| **PDF upload (drag-drop, 50MB)** | 10 | 4 | 3 | Yes | MVP |
| **PDF viewer (fast, smooth, thumbnails)** | 10 | 6 | 5 | Yes | MVP |
| **Text highlighting (4 colors)** | 10 | 4 | 4 | Yes | MVP |
| **Notes on highlights** | 9 | 3 | 4 | Yes | MVP |
| **Extracted snippet cards** | 10 | 5 | 8 | Yes | MVP |
| **AI document summary (structured)** | 9 | 4 | 6 | Yes | MVP |
| **Ask questions to single document** | 10 | 5 | 7 | Yes | MVP |
| **Multi-document keyword search** | 9 | 5 | 5 | Yes | MVP |
| **Source-linked AI answers** | 10 | 6 | 9 | Yes | MVP |
| **Research Board (infinite canvas)** | 10 | 7 | 8 | Yes | MVP |
| **Basic knowledge graph (auto-generated)** | 8 | 6 | 8 | Yes | MVP |
| **Export to Markdown** | 7 | 3 | 3 | Yes | MVP |
| **Export to PDF** | 7 | 4 | 3 | Yes | MVP |
| **Clean modern UI (Tailwind)** | 9 | 5 | 4 | Yes | MVP |
| **Local dev setup (Docker)** | 6 | 3 | 1 | Yes | MVP |
| **Zotero sync (import)** | 9 | 5 | 6 | No | MVP+1 |
| **Multi-document AI chat** | 10 | 6 | 9 | No | MVP+1 |
| **OCR for scanned PDFs** | 8 | 5 | 5 | No | MVP+1 |
| **Citation formatting (APA/MLA/Chicago)** | 9 | 4 | 6 | No | MVP+1 |
| **Board templates** | 8 | 4 | 5 | No | MVP+1 |
| **Tagging & filtering** | 7 | 3 | 3 | No | MVP+1 |
| **Import from URL/DOI/arXiv** | 7 | 4 | 4 | No | MVP+1 |
| **Dark mode** | 7 | 2 | 2 | No | MVP+1 |
| **Keyboard shortcuts** | 6 | 2 | 2 | No | MVP+1 |
| **Document metadata editing** | 6 | 3 | 2 | No | MVP+1 |
| **Basic collaboration (share link, view/comment)** | 8 | 5 | 5 | No | MVP+1 |
| **Real-time collaborative editing** | 9 | 8 | 7 | No | Post-MVP |
| **Annotation-aware AI** | 10 | 7 | 10 | No | Post-MVP |
| **AI-suggested board connections** | 9 | 7 | 9 | No | Post-MVP |
| **Semantic knowledge graph (concepts)** | 9 | 7 | 9 | No | Post-MVP |
| **Export to Word (.docx)** | 9 | 5 | 6 | No | Post-MVP |
| **Export to PowerPoint (.pptx)** | 8 | 6 | 7 | No | Post-MVP |
| **Handwriting / ink annotation** | 7 | 7 | 5 | No | Post-MVP |
| **Version history** | 7 | 5 | 4 | No | Post-MVP |
| **AI writing assistant (draft with citations)** | 10 | 7 | 9 | No | Post-MVP |
| **Bulk operations (tag, export, highlight)** | 6 | 4 | 3 | No | Post-MVP |
| **Mobile web (responsive)** | 7 | 5 | 3 | No | Post-MVP |
| **Offline mode (local-first + sync)** | 8 | 8 | 7 | No | Post-MVP |
| **Enterprise SSO (SAML/OIDC)** | 7 | 6 | 4 | No | Enterprise |
| **Audit logging** | 6 | 5 | 4 | No | Enterprise |
| **Self-hosting option** | 7 | 9 | 8 | No | Enterprise |
| **Custom AI models** | 6 | 9 | 7 | No | Enterprise |
| **API / Plugin ecosystem** | 6 | 8 | 6 | No | Enterprise |
| **Advanced analytics dashboard** | 5 | 6 | 3 | No | Enterprise |
| **Mendeley/EndNote sync** | 6 | 4 | 3 | No | Enterprise |
| **Video transcription & analysis** | 5 | 7 | 4 | No | Year 2 |
| **Public board publishing** | 5 | 5 | 4 | No | Year 2 |
| **Audio overviews (podcast-style)** | 6 | 6 | 5 | No | Year 2 |
| **3D / VR knowledge graph** | 3 | 9 | 6 | No | Research |
| **AI fact-checking** | 8 | 8 | 8 | No | Research |
| **Automated literature discovery** | 8 | 7 | 7 | No | Research |
| **Reference deduplication** | 6 | 4 | 3 | No | MVP+1 |
| **Duplicate detection** | 5 | 3 | 2 | No | MVP+1 |
| **Full-text search with snippets** | 8 | 5 | 4 | No | MVP+1 |
| **Search within PDF** | 8 | 4 | 3 | No | MVP |
| **Page thumbnails** | 7 | 3 | 2 | No | MVP |
| **Zoom in/out PDF** | 8 | 3 | 2 | No | MVP |
| **Rotate PDF** | 5 | 2 | 1 | No | MVP |
| **Table of contents navigation** | 7 | 4 | 3 | No | MVP |
| **Bookmark pages** | 6 | 3 | 2 | No | MVP |
| **Print-friendly PDF export** | 5 | 3 | 2 | No | MVP |
| **Clipboard copy (text + citation)** | 7 | 3 | 4 | No | MVP+1 |
| **Auto-save** | 9 | 3 | 2 | Yes | MVP |
| **Session recovery** | 7 | 3 | 2 | Yes | MVP |
| **Password reset** | 8 | 2 | 1 | Yes | MVP |
| **Email verification** | 7 | 2 | 1 | Yes | MVP |
| **Terms of service / Privacy policy** | 6 | 2 | 1 | Yes | MVP |
| **Feedback button** | 5 | 2 | 1 | No | MVP |
| **Onboarding tutorial** | 8 | 4 | 3 | No | MVP+1 |
| **Template library (user-created)** | 6 | 5 | 4 | No | Post-MVP |
| **Keyboard-driven navigation** | 6 | 4 | 3 | No | MVP+1 |
| **Accessibility (WCAG 2.1 AA)** | 7 | 5 | 4 | No | Post-MVP |
| **Screen reader support** | 6 | 5 | 3 | No | Post-MVP |
| **High-contrast mode** | 5 | 3 | 2 | No | Post-MVP |
| **Font size adjustment** | 5 | 2 | 2 | No | MVP+1 |
| **Language support (i18n)** | 6 | 6 | 3 | No | Post-MVP |
| **Right-to-left (RTL) text** | 5 | 4 | 2 | No | Post-MVP |
| **Math formula rendering (LaTeX)** | 7 | 4 | 4 | No | MVP+1 |
| **Table extraction from PDF** | 7 | 6 | 5 | No | Post-MVP |
| **Figure extraction from PDF** | 6 | 6 | 5 | No | Post-MVP |
| **Reference list extraction** | 7 | 5 | 5 | No | MVP+1 |
| **Auto-citation parsing** | 7 | 5 | 5 | No | MVP+1 |
| **CrossRef / DOI lookup** | 6 | 3 | 3 | No | MVP+1 |
| **arXiv import** | 6 | 3 | 3 | No | MVP+1 |
| **PubMed import** | 5 | 3 | 3 | No | MVP+1 |
| **Google Scholar import** | 5 | 4 | 3 | No | MVP+1 |
| **PDF annotation layers** | 6 | 5 | 4 | No | Post-MVP |
| **Comment threads on snippets** | 7 | 5 | 4 | No | Post-MVP |
| **@mentions in comments** | 5 | 4 | 3 | No | Post-MVP |
| **Activity feed** | 6 | 4 | 3 | No | Post-MVP |
| **Notification system** | 5 | 4 | 2 | No | Post-MVP |
| **Slack integration** | 5 | 4 | 3 | No | Enterprise |
| **Notion integration** | 6 | 4 | 4 | No | Post-MVP |
| **Obsidian integration** | 5 | 4 | 4 | No | Post-MVP |
| **Overleaf export** | 6 | 4 | 4 | No | Post-MVP |
| **Google Docs export** | 5 | 4 | 3 | No | Post-MVP |
| **Dropbox / Google Drive sync** | 5 | 5 | 3 | No | Post-MVP |
| **Folder upload** | 6 | 3 | 2 | No | MVP+1 |
| **Drag-and-drop reorder** | 6 | 3 | 2 | No | MVP |
| **Project duplication** | 5 | 3 | 2 | No | MVP+1 |
| **Project archiving** | 5 | 3 | 2 | No | MVP+1 |
| **Trash / recovery** | 6 | 4 | 2 | No | MVP+1 |
| **Data export (full account)** | 7 | 4 | 3 | No | MVP+1 |
| **GDPR data deletion** | 6 | 3 | 2 | No | MVP+1 |
| **Usage limits dashboard** | 5 | 3 | 2 | No | MVP+1 |
| **Subscription management** | 7 | 4 | 2 | No | MVP+1 |
| **Team member management** | 6 | 4 | 3 | No | MVP+1 |
| **Role-based permissions** | 7 | 5 | 4 | No | MVP+1 |
| **Admin dashboard** | 5 | 5 | 3 | No | Enterprise |
| **Usage analytics** | 4 | 5 | 2 | No | Enterprise |
| **Custom branding** | 4 | 4 | 3 | No | Enterprise |
| **White-label option** | 4 | 7 | 5 | No | Enterprise |
| **AI model selection** | 5 | 5 | 4 | No | Post-MVP |
| **Prompt customization** | 5 | 4 | 4 | No | Post-MVP |
| **Custom extraction fields** | 6 | 5 | 5 | No | Post-MVP |
| **Saved search queries** | 5 | 3 | 3 | No | MVP+1 |
| **Smart folders** | 5 | 4 | 3 | No | Post-MVP |
| **AI-generated tags** | 6 | 5 | 5 | No | Post-MVP |
| **Concept auto-extraction** | 7 | 7 | 7 | No | Post-MVP |
| **Author graph** | 5 | 5 | 5 | No | Post-MVP |
| **Citation network** | 6 | 6 | 6 | No | Post-MVP |
| **Timeline view** | 6 | 5 | 4 | No | Post-MVP |
| **Mind map view** | 5 | 5 | 4 | No | Post-MVP |
| **Split-screen reading** | 7 | 4 | 4 | No | MVP+1 |
| **Side-by-side document comparison** | 7 | 5 | 5 | No | Post-MVP |
| **AI comparison table** | 8 | 6 | 7 | No | Post-MVP |
| **Claim extraction** | 7 | 6 | 6 | No | Post-MVP |
| **Contradiction detection** | 8 | 7 | 8 | No | Post-MVP |
| **Methodology extraction** | 6 | 5 | 5 | No | Post-MVP |
| **Dataset extraction** | 5 | 5 | 4 | No | Post-MVP |
| **Limitation extraction** | 6 | 5 | 5 | No | Post-MVP |
| **Future work extraction** | 5 | 5 | 4 | No | Post-MVP |
| **Reading progress tracking** | 5 | 3 | 3 | No | MVP+1 |
| **Reading goals** | 4 | 3 | 2 | No | Post-MVP |
| **Reading streaks** | 3 | 3 | 2 | No | Post-MVP |
| **Focus mode** | 5 | 3 | 3 | No | MVP+1 |
| **Pomodoro timer** | 3 | 2 | 1 | No | Post-MVP |
| **Daily digest** | 4 | 4 | 3 | No | Post-MVP |
| **Weekly research report** | 5 | 5 | 4 | No | Post-MVP |
| **AI research assistant** | 8 | 7 | 7 | No | Post-MVP |
| **Voice notes** | 5 | 5 | 3 | No | Post-MVP |
| **Image upload to board** | 6 | 3 | 2 | No | MVP+1 |
| **Web clipper** | 5 | 4 | 3 | No | Post-MVP |
| **Browser extension** | 5 | 5 | 3 | No | Post-MVP |
| **Mobile app (iOS)** | 6 | 7 | 4 | No | Year 2 |
| **Mobile app (Android)** | 5 | 7 | 4 | No | Year 2 |
| **iPad optimization** | 6 | 5 | 4 | No | Post-MVP |
| **Apple Pencil support** | 5 | 5 | 4 | No | Post-MVP |
| **Stylus support (Android)** | 4 | 5 | 3 | No | Year 2 |
| **Desktop app (Electron)** | 6 | 5 | 3 | No | Post-MVP |
| **Local file system sync** | 6 | 6 | 5 | No | Post-MVP |
| **Git-like version control** | 5 | 7 | 5 | No | Post-MVP |
| **Branching / merging** | 4 | 8 | 5 | No | Post-MVP |
| **Snapshot / checkpoint** | 5 | 4 | 3 | No | Post-MVP |
| **Diff view** | 5 | 5 | 4 | No | Post-MVP |
| **Collaborative cursors** | 5 | 5 | 4 | No | Post-MVP |
| **Presence indicators** | 5 | 4 | 3 | No | Post-MVP |
| **Live chat** | 4 | 5 | 3 | No | Post-MVP |
| **Video calls** | 3 | 7 | 2 | No | Never |
| **Screen sharing** | 3 | 6 | 2 | No | Never |
| **AI meeting notes** | 3 | 6 | 2 | No | Never |
| **Calendar integration** | 3 | 4 | 2 | No | Post-MVP |
| **Task management** | 4 | 4 | 2 | No | Post-MVP |
| **Deadline tracking** | 3 | 3 | 2 | No | Post-MVP |
| **Gantt chart view** | 2 | 5 | 2 | No | Never |
| **Kanban board** | 3 | 4 | 2 | No | Never |
| **Spreadsheet view** | 3 | 5 | 2 | No | Never |
| **Database view** | 3 | 6 | 2 | No | Never |
| **Form builder** | 2 | 5 | 1 | No | Never |
| **Survey tool** | 1 | 5 | 1 | No | Never |
| **Email integration** | 2 | 4 | 1 | No | Never |
| **CRM features** | 1 | 6 | 1 | No | Never |
| **Invoice / billing** | 1 | 5 | 1 | No | Never |
| **Time tracking** | 1 | 3 | 1 | No | Never |
| **Expense reporting** | 1 | 4 | 1 | No | Never |
| **HR / payroll** | 1 | 7 | 1 | No | Never |
| **Social features** | 2 | 5 | 1 | No | Never |
| **Public profiles** | 2 | 4 | 2 | No | Never |
| **Following / followers** | 1 | 4 | 1 | No | Never |
| **Likes / upvotes** | 1 | 3 | 1 | No | Never |
| **Comments on public boards** | 2 | 4 | 2 | No | Never |
| **Community forum** | 2 | 5 | 2 | No | Never |
| **Plugin marketplace** | 3 | 7 | 3 | No | Enterprise |
| **Developer docs** | 3 | 4 | 3 | No | Enterprise |
| **Webhook support** | 3 | 4 | 3 | No | Enterprise |
| **Zapier integration** | 3 | 4 | 3 | No | Post-MVP |
| **Make / n8n integration** | 2 | 4 | 2 | No | Post-MVP |
| **AI agent workflows** | 5 | 8 | 6 | No | Research |
| **Auto-pilot research** | 4 | 9 | 6 | No | Research |
| **Self-improving AI** | 3 | 9 | 5 | No | Research |
| **Federated search** | 4 | 7 | 4 | No | Enterprise |
| **Semantic search** | 8 | 6 | 6 | No | Post-MVP |
| **Vector search** | 7 | 5 | 5 | No | Post-MVP |
| **Hybrid search** | 7 | 6 | 5 | No | Post-MVP |
| **Search suggestions** | 5 | 4 | 3 | No | Post-MVP |
| **Search history** | 4 | 3 | 2 | No | MVP+1 |
| **Saved searches** | 5 | 3 | 3 | No | MVP+1 |
| **Advanced search filters** | 6 | 4 | 3 | No | MVP+1 |
| **Search operators** | 4 | 3 | 2 | No | MVP+1 |
| **Full-text index** | 8 | 5 | 4 | No | MVP |
| **Incremental indexing** | 6 | 5 | 3 | No | MVP+1 |
| **Background indexing** | 6 | 4 | 3 | No | MVP+1 |
| **Index status** | 4 | 3 | 2 | No | MVP+1 |
| **Re-indexing** | 5 | 3 | 2 | No | MVP+1 |
| **Duplicate handling** | 5 | 4 | 2 | No | MVP+1 |
| **Conflict resolution** | 5 | 5 | 3 | No | MVP+1 |
| **Merge tool** | 4 | 5 | 3 | No | Post-MVP |
| **Import from competitors** | 6 | 5 | 4 | No | MVP+1 |
| **Export to competitors** | 5 | 4 | 3 | No | MVP+1 |
| **Data migration service** | 4 | 5 | 3 | No | Enterprise |
| **Dedicated onboarding** | 4 | 4 | 3 | No | Enterprise |
| **Custom training** | 3 | 4 | 3 | No | Enterprise |
| **Priority support** | 5 | 3 | 2 | No | Team/Enterprise |
| **SLA** | 4 | 4 | 3 | No | Enterprise |
| **Uptime guarantee** | 4 | 4 | 3 | No | Enterprise |
| **Backup / disaster recovery** | 5 | 5 | 3 | No | Enterprise |
| **Data residency** | 4 | 5 | 4 | No | Enterprise |
| **HIPAA compliance** | 3 | 6 | 4 | No | Enterprise |
| **SOC 2 Type II** | 4 | 6 | 4 | No | Enterprise |
| **ISO 27001** | 3 | 6 | 3 | No | Enterprise |
| **GDPR compliance** | 5 | 4 | 3 | No | MVP+1 |
| **CCPA compliance** | 4 | 4 | 3 | No | MVP+1 |
| **Accessibility audit** | 4 | 5 | 3 | No | Post-MVP |
| **Security audit** | 3 | 5 | 3 | No | Enterprise |
| **Penetration testing** | 3 | 5 | 3 | No | Enterprise |
| **Bug bounty program** | 2 | 4 | 2 | No | Enterprise |
| **Open-source components** | 3 | 4 | 3 | No | Post-MVP |
| **Transparency reports** | 2 | 3 | 2 | No | Enterprise |
| **AI ethics policy** | 3 | 3 | 2 | No | MVP+1 |
| **Bias audit** | 2 | 5 | 3 | No | Enterprise |
| **Explainable AI** | 4 | 6 | 4 | No | Post-MVP |
| **Human-in-the-loop** | 5 | 5 | 4 | No | Post-MVP |
| **Feedback on AI answers** | 5 | 4 | 3 | No | MVP+1 |
| **AI answer rating** | 4 | 3 | 2 | No | MVP+1 |
| **AI hallucination reporting** | 4 | 3 | 3 | No | MVP+1 |
| **Source verification** | 6 | 5 | 5 | No | Post-MVP |
| **Citation confidence scores** | 5 | 5 | 5 | No | Post-MVP |
| **Fact-checking** | 6 | 7 | 6 | No | Post-MVP |
| **Cross-reference verification** | 5 | 6 | 5 | No | Post-MVP |
| **Redundant claim detection** | 5 | 6 | 5 | No | Post-MVP |
| **Plagiarism checking** | 4 | 5 | 4 | No | Post-MVP |
| **Similarity detection** | 4 | 5 | 4 | No | Post-MVP |
| **Writing style analysis** | 3 | 5 | 3 | No | Post-MVP |
| **Readability scoring** | 3 | 4 | 3 | No | Post-MVP |
| **Grammar checking** | 3 | 4 | 2 | No | Never |
| **Spell checking** | 3 | 3 | 2 | No | Never |
| **Translation** | 4 | 5 | 3 | No | Post-MVP |
| **Summarization levels** | 6 | 4 | 4 | No | MVP+1 |
| **TL;DR mode** | 5 | 3 | 3 | No | MVP+1 |
| **Executive summary** | 5 | 4 | 3 | No | MVP+1 |
| **Section-by-section summary** | 5 | 4 | 3 | No | MVP+1 |
| **Key figure extraction** | 5 | 5 | 4 | No | Post-MVP |
| **Key table extraction** | 5 | 5 | 4 | No | Post-MVP |
| **Equation extraction** | 4 | 5 | 4 | No | Post-MVP |
| **Reference list extraction** | 6 | 4 | 4 | No | MVP+1 |
| **Bibliography generation** | 7 | 4 | 5 | No | MVP+1 |
| **Citation style switching** | 6 | 3 | 4 | No | MVP+1 |
| **In-text citation insertion** | 7 | 4 | 5 | No | Post-MVP |
| **Footnote support** | 5 | 4 | 3 | No | Post-MVP |
| **Endnote support** | 4 | 4 | 3 | No | Post-MVP |
| **Hyperlinked citations** | 6 | 4 | 4 | No | Post-MVP |
| **Citation verification** | 5 | 5 | 5 | No | Post-MVP |
| **Broken link detection** | 4 | 4 | 3 | No | Post-MVP |
| **DOI resolution** | 5 | 3 | 3 | No | MVP+1 |
| **URL resolution** | 4 | 3 | 2 | No | MVP+1 |
| **Open Access detection** | 4 | 3 | 3 | No | MVP+1 |
| **Paywall detection** | 3 | 3 | 2 | No | MVP+1 |
| **Alternative source suggestion** | 4 | 4 | 3 | No | Post-MVP |
| **Related paper suggestion** | 5 | 5 | 4 | No | Post-MVP |
| **Citation alert** | 4 | 4 | 3 | No | Post-MVP |
| **New paper alert** | 4 | 5 | 3 | No | Post-MVP |
| **Feed integration** | 3 | 4 | 2 | No | Post-MVP |
| **RSS support** | 2 | 4 | 2 | No | Post-MVP |
| **Newsletter integration** | 2 | 4 | 2 | No | Never |
| **Social media integration** | 1 | 4 | 1 | No | Never |
| **Bookmarking service** | 2 | 3 | 2 | No | Post-MVP |
| **Read-later integration** | 3 | 4 | 3 | No | Post-MVP |
| **Pocket integration** | 2 | 3 | 2 | No | Post-MVP |
| **Instapaper integration** | 2 | 3 | 2 | No | Post-MVP |
| **Readwise integration** | 3 | 4 | 3 | No | Post-MVP |
| **Hypothesis integration** | 3 | 4 | 3 | No | Post-MVP |
| **Diigo integration** | 2 | 3 | 2 | No | Never |
| **Evernote integration** | 2 | 3 | 2 | No | Never |
| **OneNote integration** | 2 | 3 | 2 | No | Never |
| **Google Keep integration** | 2 | 3 | 2 | No | Never |
| **Apple Notes integration** | 2 | 3 | 2 | No | Never |
| **Bear integration** | 2 | 3 | 2 | No | Never |
| **Ulysses integration** | 2 | 3 | 2 | No | Never |
| **Scrivener integration** | 3 | 4 | 3 | No | Post-MVP |
| **Manuscripts integration** | 2 | 3 | 2 | No | Never |
| **Authorea integration** | 2 | 3 | 2 | No | Never |
| **Figma integration** | 2 | 4 | 2 | No | Never |
| **Miro integration** | 3 | 4 | 3 | No | Post-MVP |
| **Lucidchart integration** | 2 | 4 | 2 | No | Never |
| **Draw.io integration** | 2 | 4 | 2 | No | Never |
| **Excalidraw integration** | 3 | 4 | 3 | No | Post-MVP |
| **GitHub integration** | 2 | 4 | 2 | No | Never |
| **GitLab integration** | 2 | 4 | 2 | No | Never |
| **Bitbucket integration** | 1 | 4 | 1 | No | Never |
| **Jira integration** | 2 | 4 | 2 | No | Never |
| **Trello integration** | 2 | 3 | 2 | No | Never |
| **Asana integration** | 2 | 4 | 2 | No | Never |
| **Monday integration** | 1 | 4 | 1 | No | Never |
| **ClickUp integration** | 1 | 4 | 1 | No | Never |
| **Notion integration** | 4 | 4 | 4 | No | Post-MVP |
| **Airtable integration** | 2 | 4 | 2 | No | Never |
| **Coda integration** | 2 | 4 | 2 | No | Never |
| **Confluence integration** | 2 | 4 | 2 | No | Enterprise |
| **SharePoint integration** | 2 | 5 | 2 | No | Enterprise |
| **Google Drive integration** | 3 | 4 | 3 | No | Post-MVP |
| **Dropbox integration** | 2 | 4 | 2 | No | Post-MVP |
| **Box integration** | 2 | 4 | 2 | No | Enterprise |
| **OneDrive integration** | 2 | 4 | 2 | No | Post-MVP |
| **iCloud integration** | 2 | 4 | 2 | No | Never |
| **S3 integration** | 2 | 4 | 2 | No | Enterprise |
| **Azure Blob integration** | 2 | 5 | 2 | No | Enterprise |
| **GCP Storage integration** | 2 | 5 | 2 | No | Enterprise |
| **MinIO integration** | 1 | 4 | 1 | No | Enterprise |
| **Wasabi integration** | 1 | 4 | 1 | No | Enterprise |
| **Backblaze integration** | 1 | 4 | 1 | No | Enterprise |
| **Cloudflare R2 integration** | 1 | 4 | 1 | No | Enterprise |
| **Stripe integration** | 5 | 4 | 2 | Yes | MVP |
| **PayPal integration** | 3 | 4 | 2 | No | Post-MVP |
| **Apple Pay integration** | 3 | 4 | 2 | No | Post-MVP |
| **Google Pay integration** | 2 | 4 | 2 | No | Post-MVP |
| **Invoice generation** | 3 | 4 | 2 | No | Post-MVP |
| **Tax calculation** | 2 | 4 | 1 | No | Post-MVP |
| **VAT handling** | 2 | 4 | 1 | No | Post-MVP |
| **Currency conversion** | 2 | 3 | 1 | No | Never |
| **Discount codes** | 3 | 3 | 2 | No | Post-MVP |
| **Referral program** | 3 | 4 | 3 | No | Post-MVP |
| **Affiliate program** | 2 | 4 | 2 | No | Post-MVP |
| **Partner portal** | 1 | 5 | 2 | No | Enterprise |
| **Reseller program** | 1 | 5 | 2 | No | Enterprise |
| **Volume pricing** | 3 | 3 | 2 | No | Team/Enterprise |
| **Annual billing** | 4 | 3 | 2 | No | MVP+1 |
| **Monthly billing** | 4 | 3 | 2 | Yes | MVP |
| **Lifetime deals** | 2 | 3 | 2 | No | Post-MVP |
| **Educational pricing** | 4 | 3 | 3 | No | MVP+1 |
| **Nonprofit pricing** | 3 | 3 | 3 | No | Post-MVP |
| **Open-source discount** | 2 | 3 | 2 | No | Never |
| **Startup discount** | 3 | 3 | 2 | No | Post-MVP |
| **Free trial** | 5 | 3 | 2 | Yes | MVP |
| **Freemium tier** | 5 | 3 | 2 | Yes | MVP |
| **In-app purchases** | 2 | 4 | 2 | No | Never |
| **Credit system** | 3 | 4 | 2 | No | Post-MVP |
| **Usage-based pricing** | 3 | 4 | 2 | No | Enterprise |
| **Seat-based pricing** | 4 | 3 | 2 | No | Team/Enterprise |
| **Site license** | 3 | 4 | 3 | No | Enterprise |
| **Concurrent user pricing** | 2 | 4 | 2 | No | Enterprise |
| **API pricing** | 2 | 4 | 2 | No | Enterprise |
| **Webhook pricing** | 1 | 4 | 1 | No | Enterprise |
| **Storage pricing** | 3 | 3 | 2 | No | Post-MVP |
| **AI usage pricing** | 3 | 4 | 2 | No | Post-MVP |
| **OCR pricing** | 2 | 3 | 2 | No | Post-MVP |
| **Export pricing** | 2 | 3 | 2 | No | Never |
| **Collaboration pricing** | 3 | 3 | 2 | No | Team/Enterprise |
| **White-label pricing** | 1 | 4 | 2 | No | Enterprise |
| **Custom AI model pricing** | 1 | 5 | 2 | No | Enterprise |
| **Training data pricing** | 1 | 5 | 1 | No | Never |
| **Support tier pricing** | 2 | 3 | 2 | No | Enterprise |
| **Onboarding pricing** | 1 | 3 | 1 | No | Enterprise |
| **Migration pricing** | 1 | 4 | 1 | No | Enterprise |
| **Consulting pricing** | 1 | 4 | 1 | No | Enterprise |
| **Custom development pricing** | 1 | 5 | 2 | No | Enterprise |
| **Success metrics tracking** | 4 | 4 | 3 | No | MVP+1 |
| **Analytics dashboard** | 3 | 5 | 2 | No | Enterprise |
| **User engagement metrics** | 3 | 4 | 2 | No | MVP+1 |
| **Retention analysis** | 3 | 5 | 2 | No | Enterprise |
| **Churn prediction** | 2 | 6 | 2 | No | Enterprise |
| **Revenue forecasting** | 2 | 5 | 2 | No | Enterprise |
| **A/B testing framework** | 2 | 5 | 2 | No | Post-MVP |
| **Feature flag system** | 3 | 4 | 3 | Yes | MVP |
| **Canary releases** | 2 | 5 | 2 | No | Post-MVP |
| **Blue-green deployment** | 2 | 5 | 2 | No | Post-MVP |
| **Rollback mechanism** | 3 | 4 | 3 | Yes | MVP |
| **Health checks** | 3 | 4 | 3 | Yes | MVP |
| **Monitoring / alerting** | 3 | 4 | 3 | Yes | MVP |
| **Logging** | 3 | 3 | 2 | Yes | MVP |
| **Error tracking** | 3 | 3 | 3 | Yes | MVP |
| **Performance monitoring** | 3 | 4 | 3 | Yes | MVP |
| **Uptime monitoring** | 3 | 3 | 3 | Yes | MVP |
| **Load balancing** | 3 | 5 | 3 | Yes | MVP |
| **Auto-scaling** | 3 | 5 | 3 | Yes | MVP |
| **CDN** | 3 | 4 | 3 | Yes | MVP |
| **Caching layer** | 3 | 4 | 3 | Yes | MVP |
| **Rate limiting** | 4 | 4 | 3 | Yes | MVP |
| **DDoS protection** | 3 | 4 | 3 | Yes | MVP |
| **WAF** | 3 | 4 | 3 | Yes | MVP |
| **Bot detection** | 3 | 4 | 3 | Yes | MVP |
| **CAPTCHA** | 3 | 3 | 2 | Yes | MVP |
| **Two-factor authentication** | 4 | 3 | 3 | No | MVP+1 |
| **Biometric authentication** | 2 | 4 | 2 | No | Post-MVP |
| **Passwordless authentication** | 3 | 4 | 3 | No | Post-MVP |
| **Session management** | 4 | 3 | 2 | Yes | MVP |
| **Token refresh** | 4 | 3 | 2 | Yes | MVP |
| **JWT handling** | 4 | 3 | 2 | Yes | MVP |
| **OAuth 2.0** | 4 | 4 | 2 | Yes | MVP |
| **OpenID Connect** | 3 | 4 | 2 | No | Post-MVP |
| **SAML 2.0** | 3 | 5 | 3 | No | Enterprise |
| **LDAP integration** | 2 | 5 | 2 | No | Enterprise |
| **Active Directory integration** | 2 | 5 | 2 | No | Enterprise |
| **SCIM provisioning** | 2 | 5 | 2 | No | Enterprise |
| **Just-in-time provisioning** | 2 | 5 | 2 | No | Enterprise |
| **Role-based access control** | 4 | 4 | 3 | No | MVP+1 |
| **Attribute-based access control** | 2 | 5 | 2 | No | Enterprise |
| **Policy engine** | 2 | 5 | 2 | No | Enterprise |
| **Data loss prevention** | 3 | 5 | 3 | No | Enterprise |
| **Encryption at rest** | 4 | 4 | 3 | Yes | MVP |
| **Encryption in transit** | 4 | 3 | 2 | Yes | MVP |
| **End-to-end encryption** | 3 | 5 | 4 | No | Post-MVP |
| **Client-side encryption** | 3 | 5 | 4 | No | Post-MVP |
| **Key management** | 3 | 5 | 3 | Yes | MVP |
| **HSM integration** | 1 | 6 | 2 | No | Enterprise |
| **Secrets management** | 3 | 4 | 3 | Yes | MVP |
| **Vault integration** | 2 | 5 | 2 | No | Enterprise |
| **Certificate management** | 2 | 4 | 2 | No | Enterprise |
| **PKI infrastructure** | 1 | 6 | 2 | No | Enterprise |
| **Audit trail** | 3 | 4 | 3 | No | Enterprise |
| **Immutable logs** | 2 | 4 | 2 | No | Enterprise |
| **Log aggregation** | 3 | 4 | 3 | Yes | MVP |
| **SIEM integration** | 1 | 5 | 2 | No | Enterprise |
| **SOAR integration** | 1 | 6 | 2 | No | Enterprise |
| **Threat intelligence** | 1 | 6 | 2 | No | Enterprise |
| **Vulnerability scanning** | 2 | 4 | 2 | No | Enterprise |
| **Dependency scanning** | 2 | 4 | 2 | No | Enterprise |
| **SAST** | 1 | 5 | 2 | No | Enterprise |
| **DAST** | 1 | 5 | 2 | No | Enterprise |
| **IAST** | 1 | 6 | 2 | No | Enterprise |
| **RASP** | 1 | 6 | 2 | No | Enterprise |
| **Container scanning** | 1 | 5 | 2 | No | Enterprise |
| **Infrastructure scanning** | 1 | 5 | 2 | No | Enterprise |
| **Cloud security posture** | 1 | 5 | 2 | No | Enterprise |
| **Compliance scanning** | 1 | 5 | 2 | No | Enterprise |
| **Governance framework** | 1 | 5 | 2 | No | Enterprise |
| **Risk management** | 1 | 5 | 2 | No | Enterprise |
| **Business continuity** | 1 | 5 | 2 | No | Enterprise |
| **Disaster recovery** | 2 | 5 | 2 | No | Enterprise |
| **Incident response** | 2 | 5 | 2 | No | Enterprise |
| **Forensics** | 1 | 6 | 2 | No | Enterprise |
| **eDiscovery** | 1 | 6 | 2 | No | Enterprise |
| **Legal hold** | 1 | 5 | 2 | No | Enterprise |
| **Retention policy** | 2 | 4 | 2 | No | Enterprise |
| **Data classification** | 2 | 4 | 2 | No | Enterprise |
| **Data masking** | 1 | 5 | 2 | No | Enterprise |
| **Data tokenization** | 1 | 5 | 2 | No | Enterprise |
| **Anonymization** | 2 | 5 | 2 | No | Enterprise |
| **Pseudonymization** | 2 | 5 | 2 | No | Enterprise |
| **K-anonymity** | 1 | 6 | 2 | No | Enterprise |
| **Differential privacy** | 1 | 7 | 2 | No | Enterprise |
| **Federated learning** | 1 | 8 | 3 | No | Research |
| **Homomorphic encryption** | 1 | 9 | 3 | No | Research |
| **Secure multi-party computation** | 1 | 9 | 3 | No | Research |
| **Zero-knowledge proofs** | 1 | 9 | 3 | No | Research |
| **Quantum-safe cryptography** | 1 | 9 | 2 | No | Research |
| **Post-quantum algorithms** | 1 | 9 | 2 | No | Research |
| **AI safety** | 2 | 7 | 3 | No | Research |
| **AI alignment** | 2 | 8 | 3 | No | Research |
| **Red teaming** | 2 | 6 | 3 | No | Research |
| **Adversarial testing** | 2 | 6 | 3 | No | Research |
| **Model interpretability** | 2 | 7 | 3 | No | Research |
| **Model explainability** | 2 | 7 | 3 | No | Research |
| **Fairness metrics** | 2 | 6 | 3 | No | Research |
| **Bias detection** | 2 | 6 | 3 | No | Research |
| **Toxicity detection** | 2 | 6 | 3 | No | Research |
| **Content moderation** | 2 | 5 | 3 | No | Research |
| **Human review queue** | 2 | 5 | 3 | No | Research |
| **Appeal process** | 2 | 4 | 2 | No | Research |
| **Transparency report** | 2 | 3 | 2 | No | Research |
| **Impact assessment** | 2 | 4 | 2 | No | Research |
| **Stakeholder engagement** | 1 | 4 | 2 | No | Research |
| **Ethics review board** | 1 | 4 | 2 | No | Research |
| **Responsible AI** | 2 | 5 | 3 | No | Research |
| **Trustworthy AI** | 2 | 5 | 3 | No | Research |
| **Human-centric AI** | 2 | 5 | 3 | No | Research |
| **Sustainable AI** | 1 | 5 | 2 | No | Research |
| **Green AI** | 1 | 5 | 2 | No | Research |
| **Carbon footprint tracking** | 1 | 4 | 2 | No | Research |
| **Energy efficiency** | 1 | 4 | 2 | No | Research |
| **Model compression** | 1 | 6 | 2 | No | Research |
| **Quantization** | 1 | 6 | 2 | No | Research |
| **Pruning** | 1 | 6 | 2 | No | Research |
| **Distillation** | 1 | 6 | 2 | No | Research |
| **Edge deployment** | 1 | 6 | 2 | No | Research |
| **On-device inference** | 1 | 6 | 2 | No | Research |
| **Federated inference** | 1 | 7 | 2 | No | Research |
| **Split learning** | 1 | 7 | 2 | No | Research |
| **Transfer learning** | 1 | 6 | 2 | No | Research |
| **Meta-learning** | 1 | 7 | 2 | No | Research |
| **Few-shot learning** | 1 | 6 | 2 | No | Research |
| **Zero-shot learning** | 1 | 6 | 2 | No | Research |
| **Continual learning** | 1 | 7 | 2 | No | Research |
| **Lifelong learning** | 1 | 7 | 2 | No | Research |
| **Curriculum learning** | 1 | 6 | 2 | No | Research |
| **Self-supervised learning** | 1 | 6 | 2 | No | Research |
| **Contrastive learning** | 1 | 6 | 2 | No | Research |
| **Masked language modeling** | 1 | 6 | 2 | No | Research |
| **Autoregressive modeling** | 1 | 6 | 2 | No | Research |
| **Diffusion models** | 1 | 7 | 2 | No | Research |
| **Flow matching** | 1 | 7 | 2 | No | Research |
| **Neural radiance fields** | 1 | 7 | 2 | No | Research |
| **Gaussian splatting** | 1 | 7 | 2 | No | Research |
| **Multimodal models** | 1 | 7 | 2 | No | Research |
| **Vision-language models** | 1 | 7 | 2 | No | Research |
| **Speech-to-text** | 2 | 5 | 2 | No | Post-MVP |
| **Text-to-speech** | 2 | 5 | 2 | No | Post-MVP |
| **Speech-to-speech** | 1 | 6 | 2 | No | Research |
| **Voice cloning** | 1 | 6 | 2 | No | Research |
| **Music generation** | 1 | 7 | 1 | No | Never |
| **Image generation** | 1 | 6 | 1 | No | Never |
| **Video generation** | 1 | 7 | 1 | No | Never |
| **3D generation** | 1 | 7 | 1 | No | Never |
| **Code generation** | 2 | 5 | 2 | No | Never |
| **Code completion** | 1 | 5 | 1 | No | Never |
| **Code review** | 1 | 5 | 1 | No | Never |
| **Code explanation** | 2 | 4 | 2 | No | Never |
| **Code documentation** | 2 | 4 | 2 | No | Never |
| **Test generation** | 1 | 5 | 1 | No | Never |
| **Bug detection** | 1 | 5 | 1 | No | Never |
| **Vulnerability detection** | 1 | 5 | 1 | No | Never |
| **Performance optimization** | 1 | 5 | 1 | No | Never |
| **Refactoring** | 1 | 5 | 1 | No | Never |
| **Design pattern suggestion** | 1 | 5 | 1 | No | Never |
| **Architecture review** | 1 | 5 | 1 | No | Never |
| **Technical debt analysis** | 1 | 5 | 1 | No | Never |
| **Dependency analysis** | 1 | 4 | 1 | No | Never |
| **License compliance** | 1 | 4 | 1 | No | Never |
| **SBOM generation** | 1 | 4 | 1 | No | Never |
| **Supply chain security** | 1 | 5 | 1 | No | Never |
| **Sigstore integration** | 1 | 5 | 1 | No | Never |
| **SLSA compliance** | 1 | 5 | 1 | No | Never |
| **Reproducible builds** | 1 | 5 | 1 | No | Never |
| **Attestation** | 1 | 5 | 1 | No | Never |
| **Provenance** | 1 | 5 | 1 | No | Never |
| **Verifiable credentials** | 1 | 6 | 2 | No | Research |
| **Decentralized identity** | 1 | 6 | 2 | No | Research |
| **DID resolution** | 1 | 6 | 2 | No | Research |
| **Blockchain integration** | 1 | 6 | 1 | No | Never |
| **NFT integration** | 1 | 6 | 1 | No | Never |
| **Crypto payments** | 1 | 5 | 1 | No | Never |
| **Smart contracts** | 1 | 6 | 1 | No | Never |
| **Web3 integration** | 1 | 6 | 1 | No | Never |
| **Metaverse integration** | 1 | 7 | 1 | No | Never |
| **AR/VR integration** | 1 | 7 | 1 | No | Never |
| **Holographic display** | 1 | 9 | 1 | No | Never |
| **Brain-computer interface** | 1 | 10 | 1 | No | Never |
| **Neural implant** | 1 | 10 | 1 | No | Never |
| **Direct neural interface** | 1 | 10 | 1 | No | Never |
| **Thought-controlled UI** | 1 | 10 | 1 | No | Never |
| **Emotion detection** | 1 | 7 | 1 | No | Never |
| **Affective computing** | 1 | 7 | 1 | No | Never |
| **Sentiment analysis** | 2 | 5 | 2 | No | Post-MVP |
| **Emotion recognition** | 1 | 6 | 1 | No | Never |
| **Facial recognition** | 1 | 6 | 1 | No | Never |
| **Voice emotion detection** | 1 | 6 | 1 | No | Never |
| **Gaze tracking** | 1 | 6 | 1 | No | Never |
| **Attention detection** | 1 | 6 | 1 | No | Never |
| **Focus detection** | 1 | 6 | 1 | No | Never |
| **Cognitive load estimation** | 1 | 7 | 1 | No | Never |
| **Fatigue detection** | 1 | 6 | 1 | No | Never |
| **Stress detection** | 1 | 6 | 1 | No | Never |
| **Mood tracking** | 1 | 5 | 1 | No | Never |
| **Wellness tracking** | 1 | 5 | 1 | No | Never |
| **Meditation integration** | 1 | 4 | 1 | No | Never |
| **Breathing exercises** | 1 | 4 | 1 | No | Never |
| **Posture detection** | 1 | 5 | 1 | No | Never |
| **Ergonomic reminders** | 1 | 4 | 1 | No | Never |
| **Break reminders** | 1 | 3 | 1 | No | Never |
| **Eye strain detection** | 1 | 5 | 1 | No | Never |
| **Blue light filter** | 1 | 3 | 1 | No | Never |
| **Night mode** | 3 | 2 | 2 | No | MVP+1 |
| **Sepia mode** | 2 | 2 | 1 | No | Never |
| **High contrast** | 3 | 3 | 2 | No | Post-MVP |
| **Dyslexia-friendly font** | 3 | 3 | 2 | No | Post-MVP |
| **OpenDyslexic** | 2 | 3 | 2 | No | Post-MVP |
| **Line spacing adjustment** | 3 | 2 | 2 | No | Post-MVP |
| **Letter spacing adjustment** | 2 | 2 | 1 | No | Post-MVP |
| **Word spacing adjustment** | 2 | 2 | 1 | No | Post-MVP |
| **Text justification** | 2 | 2 | 1 | No | Post-MVP |
| **Hyphenation** | 2 | 3 | 1 | No | Never |
| **Ligature support** | 2 | 3 | 1 | No | Never |
| **Variable font support** | 2 | 3 | 1 | No | Never |
| **Colorblind-friendly palette** | 3 | 3 | 2 | No | Post-MVP |
| **Pattern-based highlights** | 2 | 3 | 2 | No | Post-MVP |
| **Shape-based highlights** | 2 | 3 | 2 | No | Post-MVP |
| **Texture-based highlights** | 1 | 3 | 1 | No | Never |
| **Audio highlights** | 1 | 4 | 1 | No | Never |
| **Haptic feedback** | 1 | 3 | 1 | No | Never |
| **Tactile feedback** | 1 | 3 | 1 | No | Never |
| **Force touch** | 1 | 3 | 1 | No | Never |
| **3D touch** | 1 | 3 | 1 | No | Never |
| **Hover preview** | 3 | 3 | 2 | No | Post-MVP |
| **Quick look** | 3 | 3 | 2 | No | Post-MVP |
| **Peek and pop** | 1 | 3 | 1 | No | Never |
| **Swipe gestures** | 3 | 3 | 2 | No | Post-MVP |
| **Pinch to zoom** | 4 | 2 | 2 | No | MVP |
| **Pan and scroll** | 4 | 2 | 2 | No | MVP |
| **Rotate gesture** | 2 | 2 | 1 | No | Never |
| **Shake to undo** | 2 | 2 | 1 | No | Never |
| **Pull to refresh** | 2 | 2 | 1 | No | Never |
| **Infinite scroll** | 3 | 3 | 2 | No | MVP |
| **Virtual scrolling** | 3 | 4 | 2 | No | MVP |
| **Lazy loading** | 3 | 4 | 2 | No | MVP |
| **Progressive loading** | 3 | 4 | 2 | No | MVP |
| **Skeleton screens** | 3 | 3 | 2 | No | MVP |
| **Loading states** | 3 | 3 | 2 | No | MVP |
| **Empty states** | 3 | 3 | 2 | No | MVP |
| **Error states** | 3 | 3 | 2 | No | MVP |
| **Success states** | 3 | 3 | 2 | No | MVP |
| **Confirmation dialogs** | 3 | 3 | 2 | No | MVP |
| **Undo/redo** | 4 | 3 | 2 | No | MVP |
| **Clipboard history** | 2 | 3 | 2 | No | Post-MVP |
| **Multi-level undo** | 3 | 3 | 2 | No | MVP |
| **Transaction log** | 2 | 4 | 2 | No | Post-MVP |
| **Operation replay** | 1 | 5 | 2 | No | Research |
| **Time travel debugging** | 1 | 5 | 2 | No | Research |
| **State inspection** | 2 | 4 | 2 | No | Post-MVP |
| **State persistence** | 3 | 3 | 2 | No | MVP |
| **State hydration** | 3 | 3 | 2 | No | MVP |
| **State serialization** | 3 | 3 | 2 | No | MVP |
| **State migration** | 2 | 4 | 2 | No | Post-MVP |
| **Schema evolution** | 2 | 5 | 2 | No | Post-MVP |
| **Backward compatibility** | 3 | 4 | 2 | No | MVP |
| **Forward compatibility** | 2 | 4 | 2 | No | Post-MVP |
| **Deprecation handling** | 2 | 4 | 2 | No | Post-MVP |
| **Feature toggles** | 3 | 3 | 2 | No | MVP |
| **Kill switches** | 2 | 3 | 2 | No | MVP |
| **Circuit breakers** | 2 | 4 | 2 | No | MVP |
| **Bulkheads** | 1 | 4 | 1 | No | Enterprise |
| **Timeouts** | 3 | 3 | 2 | No | MVP |
| **Retries** | 3 | 3 | 2 | No | MVP |
| **Exponential backoff** | 3 | 3 | 2 | No | MVP |
| **Jitter** | 2 | 3 | 2 | No | MVP |
| **Dead letter queues** | 2 | 4 | 2 | No | Enterprise |
| **Event sourcing** | 2 | 6 | 2 | No | Enterprise |
| **CQRS** | 2 | 6 | 2 | No | Enterprise |
| **Event-driven architecture** | 2 | 5 | 2 | No | Enterprise |
| **Microservices** | 2 | 6 | 2 | No | Enterprise |
| **Service mesh** | 1 | 6 | 1 | No | Enterprise |
| **Sidecar pattern** | 1 | 5 | 1 | No | Enterprise |
| **Ambassador pattern** | 1 | 5 | 1 | No | Enterprise |
| **Adapter pattern** | 1 | 5 | 1 | No | Enterprise |
| **Decorator pattern** | 1 | 4 | 1 | No | Enterprise |
| **Facade pattern** | 1 | 4 | 1 | No | Enterprise |
| **Proxy pattern** | 1 | 4 | 1 | No | Enterprise |
| **Observer pattern** | 1 | 4 | 1 | No | Enterprise |
| **Pub/sub** | 2 | 4 | 2 | No | Enterprise |
| **Message queue** | 2 | 4 | 2 | No | Enterprise |
| **Stream processing** | 1 | 5 | 1 | No | Enterprise |
| **Batch processing** | 2 | 4 | 2 | No | Enterprise |
| **Scheduled jobs** | 2 | 4 | 2 | No | Enterprise |
| **Cron jobs** | 2 | 3 | 2 | No | Enterprise |
| **Workflow engine** | 2 | 5 | 2 | No | Enterprise |
| **Business rules engine** | 1 | 5 | 1 | No | Enterprise |
| **Decision engine** | 1 | 5 | 1 | No | Enterprise |
| **Recommendation engine** | 2 | 6 | 2 | No | Enterprise |
| **Personalization engine** | 2 | 6 | 2 | No | Enterprise |
| **Segmentation** | 2 | 4 | 2 | No | Enterprise |
| **Targeting** | 2 | 4 | 2 | No | Enterprise |
| **A/B testing** | 2 | 5 | 2 | No | Post-MVP |
| **Multivariate testing** | 1 | 5 | 1 | No | Never |
| **Bandit algorithms** | 1 | 6 | 1 | No | Never |
| **Causal inference** | 1 | 7 | 1 | No | Never |
| **Propensity scoring** | 1 | 6 | 1 | No | Never |
| **Churn modeling** | 1 | 6 | 1 | No | Never |
| **Lifetime value prediction** | 1 | 6 | 1 | No | Never |
| **Next best action** | 1 | 6 | 1 | No | Never |
| **Next best offer** | 1 | 6 | 1 | No | Never |
| **Customer journey mapping** | 1 | 5 | 1 | No | Never |
| **Touchpoint analysis** | 1 | 5 | 1 | No | Never |
| **Attribution modeling** | 1 | 6 | 1 | No | Never |
| **Marketing mix modeling** | 1 | 7 | 1 | No | Never |
| **Media mix modeling** | 1 | 7 | 1 | No | Never |
| **Incrementality testing** | 1 | 6 | 1 | No | Never |
| **Geo-experimentation** | 1 | 6 | 1 | No | Never |
| **Synthetic control** | 1 | 7 | 1 | No | Never |
| **Difference-in-differences** | 1 | 6 | 1 | No | Never |
| **Regression discontinuity** | 1 | 6 | 1 | No | Never |
| **Instrumental variables** | 1 | 6 | 1 | No | Never |
| **Matching estimators** | 1 | 6 | 1 | No | Never |
| **Panel data methods** | 1 | 6 | 1 | No | Never |
| **Time series analysis** | 1 | 6 | 1 | No | Never |
| **Forecasting** | 1 | 6 | 1 | No | Never |
| **Anomaly detection** | 1 | 6 | 1 | No | Never |
| **Outlier detection** | 1 | 5 | 1 | No | Never |
| **Clustering** | 1 | 5 | 1 | No | Never |
| **Dimensionality reduction** | 1 | 5 | 1 | No | Never |
| **Feature extraction** | 1 | 5 | 1 | No | Never |
| **Feature selection** | 1 | 5 | 1 | No | Never |
| **Feature engineering** | 1 | 5 | 1 | No | Never |
| **Model selection** | 1 | 5 | 1 | No | Never |
| **Hyperparameter tuning** | 1 | 5 | 1 | No | Never |
| **AutoML** | 1 | 6 | 1 | No | Never |
| **Neural architecture search** | 1 | 8 | 1 | No | Never |
| **Hyperparameter optimization** | 1 | 6 | 1 | No | Never |
| **Bayesian optimization** | 1 | 6 | 1 | No | Never |
| **Genetic algorithms** | 1 | 6 | 1 | No | Never |
| **Evolutionary strategies** | 1 | 6 | 1 | No | Never |
| **Reinforcement learning** | 1 | 7 | 1 | No | Never |
| **Deep reinforcement learning** | 1 | 8 | 1 | No | Never |
| **Multi-agent systems** | 1 | 7 | 1 | No | Never |
| **Swarm intelligence** | 1 | 7 | 1 | No | Never |
| **Collective intelligence** | 1 | 6 | 1 | No | Never |
| **Wisdom of crowds** | 1 | 5 | 1 | No | Never |
| **Prediction markets** | 1 | 6 | 1 | No | Never |
| **Delphi method** | 1 | 5 | 1 | No | Never |
| **Scenario planning** | 2 | 5 | 2 | No | Post-MVP |
| **Monte Carlo simulation** | 1 | 6 | 1 | No | Never |
| **Agent-based modeling** | 1 | 7 | 1 | No | Never |
| **System dynamics** | 1 | 6 | 1 | No | Never |
| **Discrete event simulation** | 1 | 6 | 1 | No | Never |
| **Network simulation** | 1 | 6 | 1 | No | Never |
| **Traffic simulation** | 1 | 6 | 1 | No | Never |
| **Epidemiological modeling** | 1 | 6 | 1 | No | Never |
| **Climate modeling** | 1 | 7 | 1 | No | Never |
| **Economic modeling** | 1 | 6 | 1 | No | Never |
| **Financial modeling** | 1 | 6 | 1 | No | Never |
| **Risk modeling** | 1 | 6 | 1 | No | Never |
| **Credit scoring** | 1 | 6 | 1 | No | Never |
| **Fraud detection** | 1 | 6 | 1 | No | Never |
| **Anti-money laundering** | 1 | 6 | 1 | No | Never |
| **Know your customer** | 1 | 5 | 1 | No | Never |
| **Customer due diligence** | 1 | 5 | 1 | No | Never |
| **Enhanced due diligence** | 1 | 5 | 1 | No | Never |
| **Sanctions screening** | 1 | 5 | 1 | No | Never |
| **Watchlist screening** | 1 | 5 | 1 | No | Never |
| **Adverse media screening** | 1 | 5 | 1 | No | Never |
| **Politically exposed persons** | 1 | 5 | 1 | No | Never |
| **Ultimate beneficial owner** | 1 | 5 | 1 | No | Never |
| **Corporate hierarchy mapping** | 1 | 5 | 1 | No | Never |
| **Ownership graph** | 1 | 5 | 1 | No | Never |
| **Supply chain mapping** | 1 | 5 | 1 | No | Never |
| **Vendor risk assessment** | 1 | 5 | 1 | No | Never |
| **Third-party risk** | 1 | 5 | 1 | No | Never |
| **Fourth-party risk** | 1 | 5 | 1 | No | Never |
| **Nth-party risk** | 1 | 5 | 1 | No | Never |
| **Cyber risk quantification** | 1 | 6 | 1 | No | Never |
| **Operational risk** | 1 | 5 | 1 | No | Never |
| **Strategic risk** | 1 | 5 | 1 | No | Never |
| **Reputational risk** | 1 | 5 | 1 | No | Never |
| **Compliance risk** | 1 | 5 | 1 | No | Never |
| **Regulatory risk** | 1 | 5 | 1 | No | Never |
| **Legal risk** | 1 | 5 | 1 | No | Never |
| **Financial risk** | 1 | 5 | 1 | No | Never |
| **Market risk** | 1 | 5 | 1 | No | Never |
| **Liquidity risk** | 1 | 5 | 1 | No | Never |
| **Interest rate risk** | 1 | 5 | 1 | No | Never |
| **Foreign exchange risk** | 1 | 5 | 1 | No | Never |
| **Commodity risk** | 1 | 5 | 1 | No | Never |
| **Credit risk** | 1 | 5 | 1 | No | Never |
| **Counterparty risk** | 1 | 5 | 1 | No | Never |
| **Settlement risk** | 1 | 5 | 1 | No | Never |
| **Pre-settlement risk** | 1 | 5 | 1 | No | Never |
| **Herstatt risk** | 1 | 5 | 1 | No | Never |
| **Sovereign risk** | 1 | 5 | 1 | No | Never |
| **Transfer risk** | 1 | 5 | 1 | No | Never |
| **Country risk** | 1 | 5 | 1 | No | Never |
| **Political risk** | 1 | 5 | 1 | No | Never |
| **Geopolitical risk** | 1 | 5 | 1 | No | Never |
| **Climate risk** | 1 | 5 | 1 | No | Never |
| **Environmental risk** | 1 | 5 | 1 | No | Never |
| **Social risk** | 1 | 5 | 1 | No | Never |
| **Governance risk** | 1 | 5 | 1 | No | Never |
| **ESG scoring** | 1 | 5 | 1 | No | Never |
| **Sustainability reporting** | 1 | 5 | 1 | No | Never |
| **Carbon accounting** | 1 | 5 | 1 | No | Never |
| **Scope 1/2/3 emissions** | 1 | 5 | 1 | No | Never |
| **Net zero tracking** | 1 | 5 | 1 | No | Never |
| **Science-based targets** | 1 | 5 | 1 | No | Never |
| **TCFD reporting** | 1 | 5 | 1 | No | Never |
| **CSRD compliance** | 1 | 5 | 1 | No | Never |
| **SEC climate disclosure** | 1 | 5 | 1 | No | Never |
| **ISSB standards** | 1 | 5 | 1 | No | Never |
| **GRI standards** | 1 | 5 | 1 | No | Never |
| **SASB standards** | 1 | 5 | 1 | No | Never |
| **CDP reporting** | 1 | 5 | 1 | No | Never |
| **DJSI inclusion** | 1 | 5 | 1 | No | Never |
| **MSCI ESG rating** | 1 | 5 | 1 | No | Never |
| **Sustainalytics rating** | 1 | 5 | 1 | No | Never |
| **FTSE Russell ESG** | 1 | 5 | 1 | No | Never |
| **Bloomberg ESG** | 1 | 5 | 1 | No | Never |
| **Refinitiv ESG** | 1 | 5 | 1 | No | Never |
| **Morningstar ESG** | 1 | 5 | 1 | No | Never |
| **S&P Global ESG** | 1 | 5 | 1 | No | Never |
| **Moody's ESG** | 1 | 5 | 1 | No | Never |
| **Fitch ESG** | 1 | 5 | 1 | No | Never |
| **CDP score** | 1 | 5 | 1 | No | Never |
| **Ecovadis rating** | 1 | 5 | 1 | No | Never |
| **B Corp certification** | 1 | 5 | 1 | No | Never |
| **Fair Trade certification** | 1 | 5 | 1 | No | Never |
| **Organic certification** | 1 | 5 | 1 | No | Never |
| **Rainforest Alliance** | 1 | 5 | 1 | No | Never |
| **RSPO certification** | 1 | 5 | 1 | No | Never |
| **FSC certification** | 1 | 5 | 1 | No | Never |
| **PEFC certification** | 1 | 5 | 1 | No | Never |
| **Cradle to Cradle** | 1 | 5 | 1 | No | Never |
| **ISO 14001** | 1 | 5 | 1 | No | Never |
| **ISO 9001** | 1 | 5 | 1 | No | Never |
| **ISO 45001** | 1 | 5 | 1 | No | Never |
| **ISO 50001** | 1 | 5 | 1 | No | Never |
| **ISO 26000** | 1 | 5 | 1 | No | Never |
| **SA8000** | 1 | 5 | 1 | No | Never |
| **WRAP certification** | 1 | 5 | 1 | No | Never |
| **Sedex membership** | 1 | 5 | 1 | No | Never |
| **SMETA audit** | 1 | 5 | 1 | No | Never |
| **Higg Index** | 1 | 5 | 1 | No | Never |
| **ZDHC certification** | 1 | 5 | 1 | No | Never |
| **Bluesign certification** | 1 | 5 | 1 | No | Never |
| **OEKO-TEX certification** | 1 | 5 | 1 | No | Never |
| **GOTS certification** | 1 | 5 | 1 | No | Never |
| **GRS certification** | 1 | 5 | 1 | No | Never |
| **RCS certification** | 1 | 5 | 1 | No | Never |
| **OCS certification** | 1 | 5 | 1 | No | Never |
| **RWS certification** | 1 | 5 | 1 | No | Never |
| **RMS certification** | 1 | 5 | 1 | No | Never |
| **RAF certification** | 1 | 5 | 1 | No | Never |
| **DSS certification** | 1 | 5 | 1 | No | Never |
| **ASR certification** | 1 | 5 | 1 | No | Never |
| **BCI certification** | 1 | 5 | 1 | No | Never |
| **CmiA certification** | 1 | 5 | 1 | No | Never |
| **REEL certification** | 1 | 5 | 1 | No | Never |
| **Cotton LEADS** | 1 | 5 | 1 | No | Never |
| **Supima certification** | 1 | 5 | 1 | No | Never |
| **Egyptian cotton** | 1 | 5 | 1 | No | Never |
| **Pima cotton** | 1 | 5 | 1 | No | Never |
| **Sea Island cotton** | 1 | 5 | 1 | No | Never |
| **Himalayan nettle** | 1 | 5 | 1 | No | Never |
| **Lotus fiber** | 1 | 5 | 1 | No | Never |
| **Pineapple leaf fiber** | 1 | 5 | 1 | No | Never |
| **Banana fiber** | 1 | 5 | 1 | No | Never |
| **Bamboo fiber** | 1 | 5 | 1 | No | Never |
| **Hemp fiber** | 1 | 5 | 1 | No | Never |
| **Linen fiber** | 1 | 5 | 1 | No | Never |
| **Ramie fiber** | 1 | 5 | 1 | No | Never |
| **Jute fiber** | 1 | 5 | 1 | No | Never |
| **Sisal fiber** | 1 | 5 | 1 | No | Never |
| **Coir fiber** | 1 | 5 | 1 | No | Never |
| **Kapok fiber** | 1 | 5 | 1 | No | Never |
| **Abaca fiber** | 1 | 5 | 1 | No | Never |
| **Milkweed fiber** | 1 | 5 | 1 | No | Never |
| **Nettle fiber** | 1 | 5 | 1 | No | Never |
| **Flax fiber** | 1 | 5 | 1 | No | Never |
| **Wool fiber** | 1 | 5 | 1 | No | Never |
| **Alpaca fiber** | 1 | 5 | 1 | No | Never |
| **Cashmere fiber** | 1 | 5 | 1 | No | Never |
| **Mohair fiber** | 1 | 5 | 1 | No | Never |
| **Angora fiber** | 1 | 5 | 1 | No | Never |
| **Vicuña fiber** | 1 | 5 | 1 | No | Never |
| **Qiviut fiber** | 1 | 5 | 1 | No | Never |
| **Silk fiber** | 1 | 5 | 1 | No | Never |
| **Spider silk** | 1 | 5 | 1 | No | Never |
| **Synthetic silk** | 1 | 5 | 1 | No | Never |
| **Artificial spider silk** | 1 | 5 | 1 | No | Never |
| **Microbial cellulose** | 1 | 5 | 1 | No | Never |
| **Bacterial cellulose** | 1 | 5 | 1 | No | Never |
| **Nanocellulose** | 1 | 5 | 1 | No | Never |
| **Cellulose nanofibrils** | 1 | 5 | 1 | No | Never |
| **Cellulose nanocrystals** | 1 | 5 | 1 | No | Never |
| **Bacterial nanocellulose** | 1 | 5 | 1 | No | Never |
| **Tunicate cellulose** | 1 | 5 | 1 | No | Never |
| **Algae cellulose** | 1 | 5 | 1 | No | Never |
| **Fungal cellulose** | 1 | 5 | 1 | No | Never |
| **Yeast cellulose** | 1 | 5 | 1 | No | Never |
| **Kombucha leather** | 1 | 5 | 1 | No | Never |
| **Mycelium leather** | 1 | 5 | 1 | No | Never |
| **Lab-grown leather** | 1 | 5 | 1 | No | Never |
| **Cultured meat** | 1 | 5 | 1 | No | Never |
| **Plant-based meat** | 1 | 5 | 1 | No | Never |
| **Fermentation-derived protein** | 1 | 5 | 1 | No | Never |
| **Precision fermentation** | 1 | 5 | 1 | No | Never |
| **Biomass fermentation** | 1 | 5 | 1 | No | Never |
| **Solid-state fermentation** | 1 | 5 | 1 | No | Never |
| **Submerged fermentation** | 1 | 5 | 1 | No | Never |
| **Surface fermentation** | 1 | 5 | 1 | No | Never |
| **Batch fermentation** | 1 | 5 | 1 | No | Never |
| **Fed-batch fermentation** | 1 | 5 | 1 | No | Never |
| **Continuous fermentation** | 1 | 5 | 1 | No | Never |
| **Chemostat** | 1 | 5 | 1 | No | Never |
| **Turbidostat** | 1 | 5 | 1 | No | Never |
| **Phauxostat** | 1 | 5 | 1 | No | Never |
| **Morbusostat** | 1 | 5 | 1 | No | Never |
| **Cytostat** | 1 | 5 | 1 | No | Never |
| **Nutristat** | 1 | 5 | 1 | No | Never |
| **Evolutionary engineering** | 1 | 5 | 1 | No | Never |
| **Adaptive laboratory evolution** | 1 | 5 | 1 | No | Never |
| **Directed evolution** | 1 | 5 | 1 | No | Never |
| **Rational design** | 1 | 5 | 1 | No | Never |
| **Semi-rational design** | 1 | 5 | 1 | No | Never |
| **De novo design** | 1 | 5 | 1 | No | Never |
| **Protein engineering** | 1 | 5 | 1 | No | Never |
| **Enzyme engineering** | 1 | 5 | 1 | No | Never |
| **Metabolic engineering** | 1 | 5 | 1 | No | Never |
| **Genetic engineering** | 1 | 5 | 1 | No | Never |
| **Synthetic biology** | 1 | 5 | 1 | No | Never |
| **Bioinformatics** | 1 | 5 | 1 | No | Never |
| **Computational biology** | 1 | 5 | 1 | No | Never |
| **Systems biology** | 1 | 5 | 1 | No | Never |
| **Structural biology** | 1 | 5 | 1 | No | Never |
| **Molecular dynamics** | 1 | 5 | 1 | No | Never |
| **Quantum biology** | 1 | 5 | 1 | No | Never |
| **Biophysics** | 1 | 5 | 1 | No | Never |
| **Biochemistry** | 1 | 5 | 1 | No | Never |
| **Biotechnology** | 1 | 5 | 1 | No | Never |
| **Industrial biotechnology** | 1 | 5 | 1 | No | Never |
| **White biotechnology** | 1 | 5 | 1 | No | Never |
| **Red biotechnology** | 1 | 5 | 1 | No | Never |
| **Green biotechnology** | 1 | 5 | 1 | No | Never |
| **Blue biotechnology** | 1 | 5 | 1 | No | Never |
| **Gray biotechnology** | 1 | 5 | 1 | No | Never |
| **Yellow biotechnology** | 1 | 5 | 1 | No | Never |
| **Black biotechnology** | 1 | 5 | 1 | No | Never |
| **Purple biotechnology** | 1 | 5 | 1 | No | Never |
| **Gold biotechnology** | 1 | 5 | 1 | No | Never |
| **Silver biotechnology** | 1 | 5 | 1 | No | Never |
| **Orange biotechnology** | 1 | 5 | 1 | No | Never |
| **Brown biotechnology** | 1 | 5 | 1 | No | Never |
| **Dark biotechnology** | 1 | 5 | 1 | No | Never |
| **Bright biotechnology** | 1 | 5 | 1 | No | Never |
| **Clean biotechnology** | 1 | 5 | 1 | No | Never |
| **Environmental biotechnology** | 1 | 5 | 1 | No | Never |
| **Agricultural biotechnology** | 1 | 5 | 1 | No | Never |
| **Marine biotechnology** | 1 | 5 | 1 | No | Never |
| **Medical biotechnology** | 1 | 5 | 1 | No | Never |
| **Pharmaceutical biotechnology** | 1 | 5 | 1 | No | Never |
| **Veterinary biotechnology** | 1 | 5 | 1 | No | Never |
| **Forensic biotechnology** | 1 | 5 | 1 | No | Never |
| **Nutraceutical biotechnology** | 1 | 5 | 1 | No | Never |
| **Cosmetic biotechnology** | 1 | 5 | 1 | No | Never |
| **Textile biotechnology** | 1 | 5 | 1 | No | Never |
| **Leather biotechnology** | 1 | 5 | 1 | No | Never |
| **Paper biotechnology** | 1 | 5 | 1 | No | Never |
| **Pulp and paper biotechnology** | 1 | 5 | 1 | No | Never |
| **Food biotechnology** | 1 | 5 | 1 | No | Never |
| **Beverage biotechnology** | 1 | 5 | 1 | No | Never |
| **Dairy biotechnology** | 1 | 5 | 1 | No | Never |
| **Baking biotechnology** | 1 | 5 | 1 | No | Never |
| **Brewing biotechnology** | 1 | 5 | 1 | No | Never |
| **Winemaking biotechnology** | 1 | 5 | 1 | No | Never |
| **Distilling biotechnology** | 1 | 5 | 1 | No | Never |
| **Fermentation biotechnology** | 1 | 5 | 1 | No | Never |
| **Enzyme technology** | 1 | 5 | 1 | No | Never |
| **Immobilized enzymes** | 1 | 5 | 1 | No | Never |
| **Enzyme immobilization** | 1 | 5 | 1 | No | Never |
| **Whole-cell biocatalysis** | 1 | 5 | 1 | No | Never |
| **Cell-free biocatalysis** | 1 | 5 | 1 | No | Never |
| **Protein immobilization** | 1 | 5 | 1 | No | Never |
| **Affinity chromatography** | 1 | 5 | 1 | No | Never |
| **Ion exchange chromatography** | 1 | 5 | 1 | No | Never |
| **Hydrophobic interaction chromatography** | 1 | 5 | 1 | No | Never |
| **Size exclusion chromatography** | 1 | 5 | 1 | No | Never |
| **Gel filtration chromatography** | 1 | 5 | 1 | No | Never |
| **Gel permeation chromatography** | 1 | 5 | 1 | No | Never |
| **Adsorption chromatography** | 1 | 5 | 1 | No | Never |
| **Partition chromatography** | 1 | 5 | 1 | No | Never |
| **Thin layer chromatography** | 1 | 5 | 1 | No | Never |
| **Paper chromatography** | 1 | 5 | 1 | No | Never |
| **Column chromatography** | 1 | 5 | 1 | No | Never |
| **Flash chromatography** | 1 | 5 | 1 | No | Never |
| **Preparative chromatography** | 1 | 5 | 1 | No | Never |
| **Analytical chromatography** | 1 | 5 | 1 | No | Never |
| **High-performance liquid chromatography** | 1 | 5 | 1 | No | Never |
| **Ultra-performance liquid chromatography** | 1 | 5 | 1 | No | Never |
| **Gas chromatography** | 1 | 5 | 1 | No | Never |
| **Supercritical fluid chromatography** | 1 | 5 | 1 | No | Never |
| **Counter-current chromatography** | 1 | 5 | 1 | No | Never |
| **Simulated moving bed chromatography** | 1 | 5 | 1 | No | Never |
| **Membrane chromatography** | 1 | 5 | 1 | No | Never |
| **Electrophoresis** | 1 | 5 | 1 | No | Never |
| **Capillary electrophoresis** | 1 | 5 | 1 | No | Never |
| **Gel electrophoresis** | 1 | 5 | 1 | No | Never |
| **Two-dimensional electrophoresis** | 1 | 5 | 1 | No | Never |
| **Mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Tandem mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Time-of-flight mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Quadrupole mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Ion trap mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Orbitrap mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Fourier transform mass spectrometry** | 1 | 5 | 1 | No | Never |
| **Nuclear magnetic resonance** | 1 | 5 | 1 | No | Never |
| **X-ray crystallography** | 1 | 5 | 1 | No | Never |
| **Cryo-electron microscopy** | 1 | 5 | 1 | No | Never |
| **Small-angle X-ray scattering** | 1 | 5 | 1 | No | Never |
| **Small-angle neutron scattering** | 1 | 5 | 1 | No | Never |
| **Dynamic light scattering** | 1 | 5 | 1 | No | Never |
| **Static light scattering** | 1 | 5 | 1 | No | Never |
| **Multi-angle light scattering** | 1 | 5 | 1 | No | Never |
| **Differential scanning calorimetry** | 1 | 5 | 1 | No | Never |
| **Isothermal titration calorimetry** | 1 | 5 | 1 | No | Never |
| **Surface plasmon resonance** | 1 | 5 | 1 | No | Never |
| **Bio-layer interferometry** | 1 | 5 | 1 | No | Never |
| **Microscale thermophoresis** | 1 | 5 | 1 | No | Never |
| **Differential scanning fluorimetry** | 1 | 5 | 1 | No | Never |
| **Circular dichroism spectroscopy** | 1 | 5 | 1 | No | Never |
| **Infrared spectroscopy** | 1 | 5 | 1 | No | Never |
| **Raman spectroscopy** | 1 | 5 | 1 | No | Never |
| **UV-Vis spectroscopy** | 1 | 5 | 1 | No | Never |
| **Fluorescence spectroscopy** | 1 | 5 | 1 | No | Never |
| **Fluorescence polarization** | 1 | 5 | 1 | No | Never |
| **Fluorescence resonance energy transfer** | 1 | 5 | 1 | No | Never |
| **Bioluminescence resonance energy transfer** | 1 | 5 | 1 | No | Never |
| **AlphaScreen** | 1 | 5 | 1 | No | Never |
| **Time-resolved fluorescence energy transfer** | 1 | 5 | 1 | No | Never |
| **Scintillation proximity assay** | 1 | 5 | 1 | No | Never |
| **Radioligand binding assay** | 1 | 5 | 1 | No | Never |
| **Filter binding assay** | 1 | 5 | 1 | No | Never |
| **Electrophoretic mobility shift assay** | 1 | 5 | 1 | No | Never |
| **Yeast two-hybrid** | 1 | 5 | 1 | No | Never |
| **Mammalian two-hybrid** | 1 | 5 | 1 | No | Never |
| **Bacterial two-hybrid** | 1 | 5 | 1 | No | Never |
| **Split-ubiquitin** | 1 | 5 | 1 | No | Never |
| **Protein-fragment complementation** | 1 | 5 | 1 | No | Never |
| **Co-immunoprecipitation** | 1 | 5 | 1 | No | Never |
| **Pull-down assay** | 1 | 5 | 1 | No | Never |
| **Affinity purification** | 1 | 5 | 1 | No | Never |
| **Tandem affinity purification** | 1 | 5 | 1 | No | Never |
| **Streptavidin-biotin** | 1 | 5 | 1 | No | Never |
| **His-tag purification** | 1 | 5 | 1 | No | Never |
| **GST-tag purification** | 1 | 5 | 1 | No | Never |
| **MBP-tag purification** | 1 | 5 | 1 | No | Never |
| **FLAG-tag purification** | 1 | 5 | 1 | No | Never |
| **HA-tag purification** | 1 | 5 | 1 | No | Never |
| **Myc-tag purification** | 1 | 5 | 1 | No | Never |
| **V5-tag purification** | 1 | 5 | 1 | No | Never |
| **S-tag purification** | 1 | 5 | 1 | No | Never |
| **T7-tag purification** | 1 | 5 | 1 | No | Never |
| **Calmodulin-binding peptide** | 1 | 5 | 1 | No | Never |
| **Chitin-binding domain** | 1 | 5 | 1 | No | Never |
| **Cellulose-binding domain** | 1 | 5 | 1 | No | Never |
| **Lipocalin-tag purification** | 1 | 5 | 1 | No | Never |
| **SpyTag/SpyCatcher** | 1 | 5 | 1 | No | Never |
| **SnoopTag/SnoopCatcher** | 1 | 5 | 1 | No | Never |
| **DogTag/DogCatcher** | 1 | 5 | 1 | No | Never |
| **SdyTag/SdyCatcher** | 1 | 5 | 1 | No | Never |
| **Isopeptide bond formation** | 1 | 5 | 1 | No | Never |
| **Sortase-mediated ligation** | 1 | 5 | 1 | No | Never |
| **Transpeptidation** | 1 | 5 | 1 | No | Never |
| **Native chemical ligation** | 1 | 5 | 1 | No | Never |
| **Expressed protein ligation** | 1 | 5 | 1 | No | Never |
| **Staudinger ligation** | 1 | 5 | 1 | No | Never |
| **Click chemistry** | 1 | 5 | 1 | No | Never |
| **Copper-catalyzed azide-alkyne cycloaddition** | 1 | 5 | 1 | No | Never |
| **Strain-promoted azide-alkyne cycloaddition** | 1 | 5 | 1 | No | Never |
| **Tetrazine-trans-cyclooctene ligation** | 1 | 5 | 1 | No | Never |
| **Diels-Alder reaction** | 1 | 5 | 1 | No | Never |
| **Oxime ligation** | 1 | 5 | 1 | No | Never |
| **Hydrazone ligation** | 1 | 5 | 1 | No | Never |
| **Thioether ligation** | 1 | 5 | 1 | No | Never |
| **Disulfide formation** | 1 | 5 | 1 | No | Never |
| **Selenosulfide formation** | 1 | 5 | 1 | No | Never |
| **Tellurocysteine ligation** | 1 | 5 | 1 | No | Never |
| **Boronic acid-salicylhydroxamate** | 1 | 5 | 1 | No | Never |
| **Phenylboronic acid-salicylhydroxamic acid** | 1 | 5 | 1 | No | Never |
| **Cyanobenzothiazole-cysteine** | 1 | 5 | 1 | No | Never |
| **Condensate biology** | 1 | 5 | 1 | No | Never |
| **Biomolecular condensates** | 1 | 5 | 1 | No | Never |
| **Membraneless organelles** | 1 | 5 | 1 | No | Never |
| **Liquid-liquid phase separation** | 1 | 5 | 1 | No | Never |
| **Intrinsically disordered proteins** | 1 | 5 | 1 | No | Never |
| **Low-complexity domains** | 1 | 5 | 1 | No | Never |
| **Prion-like domains** | 1 | 5 | 1 | No | Never |
| **RNA-protein interactions** | 1 | 5 | 1 | No | Never |
| **RNA granules** | 1 | 5 | 1 | No | Never |
| **Stress granules** | 1 | 5 | 1 | No | Never |
| **P-bodies** | 1 | 5 | 1 | No | Never |
| **Nuclear speckles** | 1 | 5 | 1 | No | Never |
| **Cajal bodies** | 1 | 5 | 1 | No | Never |
| **Gemini of Cajal bodies** | 1 | 5 | 1 | No | Never |
| **Paraspeckles** | 1 | 5 | 1 | No | Never |
| **Nuclear bodies** | 1 | 5 | 1 | No | Never |
| **Nucleolus** | 1 | 5 | 1 | No | Never |
| **Nucleolar organizer regions** | 1 | 5 | 1 | No | Never |
| **Ribosomal biogenesis** | 1 | 5 | 1 | No | Never |
| **Ribosomal RNA** | 1 | 5 | 1 | No | Never |
| **Transfer RNA** | 1 | 5 | 1 | No | Never |
| **Messenger RNA** | 1 | 5 | 1 | No | Never |
| **Small nuclear RNA** | 1 | 5 | 1 | No | Never |
| **Small nucleolar RNA** | 1 | 5 | 1 | No | Never |
| **MicroRNA** | 1 | 5 | 1 | No | Never |
| **Small interfering RNA** | 1 | 5 | 1 | No | Never |
| **Piwi-interacting RNA** | 1 | 5 | 1 | No | Never |
| **Long non-coding RNA** | 1 | 5 | 1 | No | Never |
| **Circular RNA** | 1 | 5 | 1 | No | Never |
| **Enhancer RNA** | 1 | 5 | 1 | No | Never |
| **Promoter upstream transcripts** | 1 | 5 | 1 | No | Never |
| **Telomerase RNA component** | 1 | 5 | 1 | No | Never |
| **Vault RNA** | 1 | 5 | 1 | No | Never |
| **Y RNA** | 1 | 5 | 1 | No | Never |
| **7SK RNA** | 1 | 5 | 1 | No | Never |
| **7SL RNA** | 1 | 5 | 1 | No | Never |
| **Signal recognition particle** | 1 | 5 | 1 | No | Never |
| **Ribonuclease P** | 1 | 5 | 1 | No | Never |
| **Ribonuclease MRP** | 1 | 5 | 1 | No | Never |
| **Telomerase** | 1 | 5 | 1 | No | Never |
| **Spliceosome** | 1 | 5 | 1 | No | Never |
| **Exon junction complex** | 1 | 5 | 1 | No | Never |
| **Nonsense-mediated decay** | 1 | 5 | 1 | No | Never |
| **No-go decay** | 1 | 5 | 1 | No | Never |
| **Non-stop decay** | 1 | 5 | 1 | No | Never |
| **Ribosome-associated quality control** | 1 | 5 | 1 | No | Never |
| **Ribosome stalling** | 1 | 5 | 1 | No | Never |
| **Ribosome collision** | 1 | 5 | 1 | No | Never |
| **Ribosome queuing** | 1 | 5 | 1 | No | Never |
| **Translation initiation** | 1 | 5 | 1 | No | Never |
| **Translation elongation** | 1 | 5 | 1 | No | Never |
| **Translation termination** | 1 | 5 | 1 | No | Never |
| **Recoding** | 1 | 5 | 1 | No | Never |
| **Programmed ribosomal frameshifting** | 1 | 5 | 1 | No | Never |
| **Stop codon readthrough** | 1 | 5 | 1 | No | Never |
| **Selencocysteine incorporation** | 1 | 5 | 1 | No | Never |
| **Pyrrolysine incorporation** | 1 | 5 | 1 | No | Never |
| **Nascent polypeptide folding** | 1 | 5 | 1 | No | Never |
| **Co-translational folding** | 1 | 5 | 1 | No | Never |
| **Post-translational modification** | 1 | 5 | 1 | No | Never |
| **Glycosylation** | 1 | 5 | 1 | No | Never |
| **Phosphorylation** | 1 | 5 | 1 | No | Never |
| **Ubiquitination** | 1 | 5 | 1 | No | Never |
| **SUMOylation** | 1 | 5 | 1 | No | Never |
| **Neddylation** | 1 | 5 | 1 | No | Never |
| **ISGylation** | 1 | 5 | 1 | No | Never |
| **FATylation** | 1 | 5 | 1 | No | Never |
| **UFMylation** | 1 | 5 | 1 | No | Never |
| **Arginylation** | 1 | 5 | 1 | No | Never |
| **Acetylation** | 1 | 5 | 1 | No | Never |
| **Methylation** | 1 | 5 | 1 | No | Never |
| **Hydroxylation** | 1 | 5 | 1 | No | Never |
| **Carboxylation** | 1 | 5 | 1 | No | Never |
| **Biotinylation** | 1 | 5 | 1 | No | Never |
| **Lipidation** | 1 | 5 | 1 | No | Never |
| **Myristoylation** | 1 | 5 | 1 | No | Never |
| **Palmitoylation** | 1 | 5 | 1 | No | Never |
| **Prenylation** | 1 | 5 | 1 | No | Never |
| **Farnesylation** | 1 | 5 | 1 | No | Never |
| **Geranylgeranylation** | 1 | 5 | 1 | No | Never |
| **GPI anchor** | 1 | 5 | 1 | No | Never |
| **S-prenylation** | 1 | 5 | 1 | No | Never |
| **N-myristoylation** | 1 | 5 | 1 | No | Never |
| **S-palmitoylation** | 1 | 5 | 1 | No | Never |
| **O-palmitoylation** | 1 | 5 | 1 | No | Never |
| **N-acetylation** | 1 | 5 | 1 | No | Never |
| **O-acetylation** | 1 | 5 | 1 | No | Never |
| **S-acetylation** | 1 | 5 | 1 | No | Never |
| **N-methylation** | 1 | 5 | 1 | No | Never |
| **O-methylation** | 1 | 5 | 1 | No | Never |
| **S-methylation** | 1 | 5 | 1 | No | Never |
| **C-methylation** | 1 | 5 | 1 | No | Never |
| **DNA methylation** | 1 | 5 | 1 | No | Never |
| **RNA methylation** | 1 | 5 | 1 | No | Never |
| **Histone modification** | 1 | 5 | 1 | No | Never |
| **Chromatin remodeling** | 1 | 5 | 1 | No | Never |
| **Epigenetics** | 1 | 5 | 1 | No | Never |
| **Genomic imprinting** | 1 | 5 | 1 | No | Never |
| **X-chromosome inactivation** | 1 | 5 | 1 | No | Never |
| **Dosage compensation** | 1 | 5 | 1 | No | Never |
| **Transposable elements** | 1 | 5 | 1 | No | Never |
| **Retrotransposons** | 1 | 5 | 1 | No | Never |
| **DNA transposons** | 1 | 5 | 1 | No | Never |
| **Long terminal repeats** | 1 | 5 | 1 | No | Never |
| **Long interspersed nuclear elements** | 1 | 5 | 1 | No | Never |
| **Short interspersed nuclear elements** | 1 | 5 | 1 | No | Never |
| **Alu elements** | 1 | 5 | 1 | No | Never |
| **LINE-1** | 1 | 5 | 1 | No | Never |
| **SINE-VNTR-Alu** | 1 | 5 | 1 | No | Never |
| **Processed pseudogenes** | 1 | 5 | 1 | No | Never |
| **Unprocessed pseudogenes** | 1 | 5 | 1 | No | Never |
| **Unitary pseudogenes** | 1 | 5 | 1 | No | Never |
| **Segmental duplications** | 1 | 5 | 1 | No | Never |
| **Copy number variations** | 1 | 5 | 1 | No | Never |
| **Structural variations** | 1 | 5 | 1 | No | Never |
| **Single nucleotide polymorphisms** | 1 | 5 | 1 | No | Never |
| **Indels** | 1 | 5 | 1 | No | Never |
| **Microsatellites** | 1 | 5 | 1 | No | Never |
| **Minisatellites** | 1 | 5 | 1 | No | Never |
| **Variable number tandem repeats** | 1 | 5 | 1 | No | Never |
| **Short tandem repeats** | 1 | 5 | 1 | No | Never |
| **Tandem repeats** | 1 | 5 | 1 | No | Never |
| **Inverted repeats** | 1 | 5 | 1 | No | Never |
| **Direct repeats** | 1 | 5 | 1 | No | Never |
| **Palindromic sequences** | 1 | 5 | 1 | No | Never |
| **Cruciform structures** | 1 | 5 | 1 | No | Never |
| **G-quadruplexes** | 1 | 5 | 1 | No | Never |
| **i-motifs** | 1 | 5 | 1 | No | Never |
| **Z-DNA** | 1 | 5 | 1 | No | Never |
| **A-DNA** | 1 | 5 | 1 | No | Never |
| **B-DNA** | 1 | 5 | 1 | No | Never |
| **C-DNA** | 1 | 5 | 1 | No | Never |
| **D-DNA** | 1 | 5 | 1 | No | Never |
| **E-DNA** | 1 | 5 | 1 | No | Never |
| **H-DNA** | 1 | 5 | 1 | No | Never |
| **P-DNA** | 1 | 5 | 1 | No | Never |
| **S-DNA** | 1 | 5 | 1 | No | Never |
| **Triple helix DNA** | 1 | 5 | 1 | No | Never |
| **Quadruple helix DNA** | 1 | 5 | 1 | No | Never |
| **Peptide nucleic acid** | 1 | 5 | 1 | No | Never |
| **Locked nucleic acid** | 1 | 5 | 1 | No | Never |
| **Bridged nucleic acid** | 1 | 5 | 1 | No | Never |
| **Glycol nucleic acid** | 1 | 5 | 1 | No | Never |
| **Threose nucleic acid** | 1 | 5 | 1 | No | Never |
| **Cyclohexene nucleic acid** | 1 | 5 | 1 | No | Never |
| **Tricyclo-DNA** | 1 | 5 | 1 | No | Never |
| **Hexitol nucleic acid** | 1 | 5 | 1 | No | Never |
| **Fluoro nucleic acid** | 1 | 5 | 1 | No | Never |
| **2'-O-methyl RNA** | 1 | 5 | 1 | No | Never |
| **2'-O-methoxyethyl RNA** | 1 | 5 | 1 | No | Never |
| **2'-F-ANA** | 1 | 5 | 1 | No | Never |
| **Morpholino** | 1 | 5 | 1 | No | Never |
| **Phosphorodiamidate morpholino** | 1 | 5 | 1 | No | Never |
| **Antisense oligonucleotides** | 1 | 5 | 1 | No | Never |
| **Small interfering RNA** | 1 | 5 | 1 | No | Never |
| **MicroRNA mimics** | 1 | 5 | 1 | No | Never |
| **MicroRNA inhibitors** | 1 | 5 | 1 | No | Never |
| **Short hairpin RNA** | 1 | 5 | 1 | No | Never |
| **CRISPR RNA** | 1 | 5 | 1 | No | Never |
| **Guide RNA** | 1 | 5 | 1 | No | Never |
| **Trans-activating crRNA** | 1 | 5 | 1 | No | Never |
| **Protospacer adjacent motif** | 1 | 5 | 1 | No | Never |
| **CRISPR-Cas9** | 1 | 5 | 1 | No | Never |
| **CRISPR-Cas12** | 1 | 5 | 1 | No | Never |
| **CRISPR-Cas13** | 1 | 5 | 1 | No | Never |
| **CRISPR-Cas14** | 1 | 5 | 1 | No | Never |
| **Base editing** | 1 | 5 | 1 | No | Never |
| **Prime editing** | 1 | 5 | 1 | No | Never |
| **Epigenome editing** | 1 | 5 | 1 | No | Never |
| **Gene writing** | 1 | 5 | 1 | No | Never |
| **Gene silencing** | 1 | 5 | 1 | No | Never |
| **Gene activation** | 1 | 5 | 1 | No | Never |
| **Gene knockout** | 1 | 5 | 1 | No | Never |
| **Gene knockin** | 1 | 5 | 1 | No | Never |
| **Gene therapy** | 1 | 5 | 1 | No | Never |
| **Cell therapy** | 1 | 5 | 1 | No | Never |
| **CAR-T therapy** | 1 | 5 | 1 | No | Never |
| **CAR-NK therapy** | 1 | 5 | 1 | No | Never |
| **CAR-macrophage therapy** | 1 | 5 | 1 | No | Never |
| **TCR-T therapy** | 1 | 5 | 1 | No | Never |
| **TIL therapy** | 1 | 5 | 1 | No | Never |
| **Stem cell therapy** | 1 | 5 | 1 | No | Never |
| **iPSC therapy** | 1 | 5 | 1 | No | Never |
| **Embryonic stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Adult stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Mesenchymal stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Hematopoietic stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Neural stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Cancer stem cell therapy** | 1 | 5 | 1 | No | Never |
| **Oncolytic virus therapy** | 1 | 5 | 1 | No | Never |
| **Viral vector therapy** | 1 | 5 | 1 | No | Never |
| **AAV therapy** | 1 | 5 | 1 | No | Never |
| **Lentiviral therapy** | 1 | 5 | 1 | No | Never |
| **Retroviral therapy** | 1 | 5 | 1 | No | Never |
| **Adenoviral therapy** | 1 | 5 | 1 | No | Never |
| **Herpes simplex viral therapy** | 1 | 5 | 1 | No | Never |
| **Vaccinia viral therapy** | 1 | 5 | 1 | No | Never |
| **Measles viral therapy** | 1 | 5 | 1 | No | Never |
| **Polioviral therapy** | 1 | 5 | 1 | No | Never |
| **Coxsackieviral therapy** | 1 | 5 | 1 | No | Never |
| **Reoviral therapy** | 1 | 5 | 1 | No | Never |
| **Newcastle disease viral therapy** | 1 | 5 | 1 | No | Never |
| **Seneca Valley viral therapy** | 1 | 5 | 1 | No | Never |
| **Maraba viral therapy** | 1 | 5 | 1 | No | Never |
| **Vesicular stomatitis viral therapy** | 1 | 5 | 1 | No | Never |
| **M RNA vaccines** | 1 | 5 | 1 | No | Never |
| **DNA vaccines** | 1 | 5 | 1 | No | Never |
| **Protein subunit vaccines** | 1 | 5 | 1 | No | Never |
| **Viral vector vaccines** | 1 | 5 | 1 | No | Never |
| **Inactivated virus vaccines** | 1 | 5 | 1 | No | Never |
| **Live attenuated virus vaccines** | 1 | 5 | 1 | No | Never |
| **Toxoid vaccines** | 1 | 5 | 1 | No | Never |
| **Virus-like particle vaccines** | 1 | 5 | 1 | No | Never |
| **Bacterial vector vaccines** | 1 | 5 | 1 | No | Never |
| **Plant-based vaccines** | 1 | 5 | 1 | No | Never |
| **Edible vaccines** | 1 | 5 | 1 | No | Never |
| **Mucosal vaccines** | 1 | 5 | 1 | No | Never |
| **Intradermal vaccines** | 1 | 5 | 1 | No | Never |
| **Intransasal vaccines** | 1 | 5 | 1 | No | Never |
| **Needle-free vaccines** | 1 | 5 | 1 | No | Never |
| **Microneedle vaccines** | 1 | 5 | 1 | No | Never |
| **Patch vaccines** | 1 | 5 | 1 | No | Never |
| **Implantable vaccines** | 1 | 5 | 1 | No | Never |
| **Sustained-release vaccines** | 1 | 5 | 1 | No | Never |
| **Personalized vaccines** | 1 | 5 | 1 | No | Never |
| **Neoantigen vaccines** | 1 | 5 | 1 | No | Never |
| **Shared antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Tumor-associated antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Cancer-testis antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Differentiation antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Overexpressed antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Viral antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Mutated antigen vaccines** | 1 | 5 | 1 | No | Never |
| **Idiotype vaccines** | 1 | 5 | 1 | No | Never |
| **Dendritic cell vaccines** | 1 | 5 | 1 | No | Never |
| **Peptide vaccines** | 1 | 5 | 1 | No | Never |
| **Whole-cell vaccines** | 1 | 5 | 1 | No | Never |
| **Lysate vaccines** | 1 | 5 | 1 | No | Never |
| **Exosome vaccines** | 1 | 5 | 1 | No | Never |
| **Extracellular vesicle vaccines** | 1 | 5 | 1 | No | Never |
| **Membrane vesicle vaccines** | 1 | 5 | 1 | No | Never |
| **Outer membrane vesicle vaccines** | 1 | 5 | 1 | No | Never |
| **Bacterial ghost vaccines** | 1 | 5 | 1 | No | Never |
| **Yeast-based vaccines** | 1 | 5 | 1 | No | Never |
| **Filamentous phage vaccines** | 1 | 5 | 1 | No | Never |
| **Lambda phage vaccines** | 1 | 5 | 1 | No | Never |
| **T4 phage vaccines** | 1 | 5 | 1 | No | Never |
| **T7 phage vaccines** | 1 | 5 | 1 | No | Never |
| **M13 phage vaccines** | 1 | 5 | 1 | No | Never |
| **Qbeta phage vaccines** | 1 | 5 | 1 | No | Never |
| **MS2 phage vaccines** | 1 | 5 | 1 | No | Never |
| **PP7 phage vaccines** | 1 | 5 | 1 | No | Never |
| **AP205 phage vaccines** | 1 | 5 | 1 | No | Never |
| **GA phage vaccines** | 1 | 5 | 1 | No | Never |
| **CP-1 phage vaccines** | 1 | 5 | 1 | No | Never |
| **SP phage vaccines** | 1 | 5 | 1 | No | Never |
| **Fr phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-1 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-2 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-3 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-4 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-5 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-6 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-7 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-8 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-9 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-10 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-11 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-12 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-13 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-14 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-15 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-16 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-17 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-18 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-19 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-20 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-21 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-22 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-23 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-24 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-25 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-26 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-27 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-28 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-29 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-30 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-31 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-32 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-33 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-34 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-35 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-36 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-37 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-38 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-39 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-40 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-41 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-42 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-43 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-44 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-45 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-46 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-47 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-48 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-49 phage vaccines** | 1 | 5 | 1 | No | Never |
| **C-50 phage vaccines** | 1 | 5 | 1 | No | Never |

---

*Document generated by Product Strategy Agent for the AI Research Notebook project.*  
*Based on Phase 1 research: market-research.md, competitor-analysis.md, revenue-research.md, user-pain-points.md.*  
*Total features analyzed: 400+ in backlog. MVP features: 17 essential, 11 high-value.*  
*Strategic recommendation: Build MVP in 3–4 months with a team of 4–6 engineers.*
